AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|YEAR
0-14|0.9|1.0|1.0|585|IV(a) Neuroblastoma and ganglioneuroblastoma|58268801|2006
0-19|0.7|0.8|0.7|592|IV(a) Neuroblastoma and ganglioneuroblastoma|78718627|2006
0-19|0.7|0.8|0.8|592|IV(a) Neuroblastoma and ganglioneuroblastoma|78718627|2006
0-14|~|~|~|~|II(e) Unspecified lymphomas|59582794|2005
0-19|0.0|0.0|0.0|27|II(e) Unspecified lymphomas|80201013|2005
0-19|0.0|0.0|0.0|27|II(e) Unspecified lymphomas|80201013|2005
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|58268801|2006
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|78718627|2006
0-19|1.2|1.3|1.3|991|II(a) Hodgkin lymphomas|78718627|2006
0-19|0.0|0.1|0.0|31|XII(a) Other specified malignant tumors|79979457|2004
0-14|0.0|0.1|0.0|23|XII(b) Other unspecified malignant tumors|59678430|2004
0-19|0.0|0.1|0.0|36|XII(b) Other unspecified malignant tumors|79979457|2004
0-14|0.6|0.7|0.6|364|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58268801|2006
0-19|0.8|0.9|0.8|668|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78718627|2006
0-19|0.0|0.1|0.0|36|XII(b) Other unspecified malignant tumors|79979457|2004
0-14|14.8|15.4|15.1|9069|All ICCC Groups Combined|59582794|2005
0-19|16.5|17.1|16.8|13598|All ICCC Groups Combined|80201013|2005
0-19|0.8|0.9|0.8|668|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78718627|2006
0-14|0.2|0.3|0.2|141|II(c) Burkitt lymphoma|58268801|2006
0-19|0.2|0.3|0.2|188|II(c) Burkitt lymphoma|78718627|2006
0-19|16.7|17.2|17.0|13598|All ICCC Groups Combined|80201013|2005
0-19|0.2|0.3|0.2|188|II(c) Burkitt lymphoma|78718627|2006
0-14|0.1|0.2|0.1|74|II(d) Miscellaneous lymphoreticular neoplasms|58268801|2006
0-19|0.1|0.1|0.1|80|II(d) Miscellaneous lymphoreticular neoplasms|78718627|2006
0-14|4.6|4.9|4.8|2870|I Leukemias, myeloproliferative & myelodysplastic diseases|59582794|2005
0-19|4.2|4.5|4.3|3488|I Leukemias, myeloproliferative & myelodysplastic diseases|80201013|2005
0-19|4.2|4.5|4.3|3488|I Leukemias, myeloproliferative & myelodysplastic diseases|80201013|2005
0-14|3.5|3.8|3.7|2195|I(a) Lymphoid leukemias|59582794|2005
0-19|3.0|3.3|3.1|2524|I(a) Lymphoid leukemias|80201013|2005
0-19|3.0|3.3|3.1|2524|I(a) Lymphoid leukemias|80201013|2005
0-19|0.1|0.1|0.1|80|II(d) Miscellaneous lymphoreticular neoplasms|78718627|2006
0-19|3.1|3.4|3.3|2612|I(a) Lymphoid leukemias|79979457|2004
0-14|0.6|0.8|0.7|424|I(b) Acute myeloid leukemias|59582794|2005
0-19|0.7|0.8|0.7|598|I(b) Acute myeloid leukemias|80201013|2005
0-19|0.7|0.8|0.7|598|I(b) Acute myeloid leukemias|80201013|2005
0-14|~|~|~|~|II(e) Unspecified lymphomas|58268801|2006
0-19|0.0|0.0|0.0|23|II(e) Unspecified lymphomas|78718627|2006
0-19|0.0|0.0|0.0|23|II(e) Unspecified lymphomas|78718627|2006
0-19|0.0|0.0|0.0|24|X(d) Gonadal carcinomas|78112034|2003
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58431001|2003
0-14|0.1|0.2|0.1|81|I(c) Chronic myeloproliferative diseases|59582794|2005
0-19|0.2|0.2|0.2|148|I(c) Chronic myeloproliferative diseases|80201013|2005
0-14|3.0|3.3|3.1|1821|III CNS and misc intracranial and intraspinal neoplasms|58268801|2006
0-19|2.8|3.0|2.9|2275|III CNS and misc intracranial and intraspinal neoplasms|78718627|2006
0-19|2.8|3.0|2.9|2275|III CNS and misc intracranial and intraspinal neoplasms|78718627|2006
0-19|0.0|0.1|0.0|30|X(e) Other and unspecified malignant gonadal tumors|78112034|2003
0-19|0.0|0.1|0.0|30|X(e) Other and unspecified malignant gonadal tumors|78112034|2003
0-19|0.2|0.2|0.2|148|I(c) Chronic myeloproliferative diseases|80201013|2005
0-14|0.1|0.2|0.2|91|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59582794|2005
0-19|0.1|0.2|0.1|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80201013|2005
0-14|0.6|0.7|0.6|382|XI Other malignant epithelial neoplasms and malignant melanomas|58431001|2003
0-19|1.6|1.8|1.7|1364|XI Other malignant epithelial neoplasms and malignant melanomas|78112034|2003
0-19|1.7|1.8|1.7|1364|XI Other malignant epithelial neoplasms and malignant melanomas|78112034|2003
0-19|0.0|0.0|0.0|17|XI(a) Adrenocortical carcinomas|79979457|2004
0-19|0.0|0.0|0.0|17|XI(a) Adrenocortical carcinomas|79979457|2004
0-14|0.2|0.3|0.3|168|III(a) Ependymomas and choroid plexus tumor|58268801|2006
0-19|0.2|0.3|0.3|214|III(a) Ependymomas and choroid plexus tumor|78718627|2006
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|58431001|2003
0-19|0.0|0.0|0.0|20|XI(a) Adrenocortical carcinomas|78112034|2003
0-14|0.2|0.3|0.3|150|XI(b) Thyroid carcinomas|59678430|2004
0-19|0.6|0.7|0.7|538|XI(b) Thyroid carcinomas|79979457|2004
0-19|0.2|0.3|0.3|214|III(a) Ependymomas and choroid plexus tumor|78718627|2006
0-14|1.4|1.6|1.5|859|III(b) Astrocytomas|58268801|2006
0-19|1.3|1.5|1.4|1107|III(b) Astrocytomas|78718627|2006
0-14|0.0|0.0|0.0|51|VIII(b) Chondrosarcomas|274499921|2002-2006
0-19|0.0|0.0|0.0|126|VIII(b) Chondrosarcomas|368492797|2002-2006
0-19|0.0|0.0|0.0|133|VIII(b) Chondrosarcomas|408000943|2002-2006
0-19|0.0|0.0|0.0|20|XI(a) Adrenocortical carcinomas|78112034|2003
0-14|0.2|0.3|0.2|126|XI(b) Thyroid carcinomas|58431001|2003
0-19|0.6|0.7|0.6|476|XI(b) Thyroid carcinomas|78112034|2003
0-19|0.6|0.7|0.7|538|XI(b) Thyroid carcinomas|79979457|2004
0-14|0.0|0.1|0.0|23|XI(c) Nasopharyngeal carcinomas|59678430|2004
0-19|0.0|0.1|0.1|44|XI(c) Nasopharyngeal carcinomas|79979457|2004
0-19|4.3|4.6|4.5|3533|I Leukemias, myeloproliferative & myelodysplastic diseases|78718627|2006
0-14|0.2|0.3|0.2|635|VIII(c) Ewing tumor and related sarcomas of bone|274499921|2002-2006
0-19|0.3|0.3|0.3|1041|VIII(c) Ewing tumor and related sarcomas of bone|368492797|2002-2006
0-19|0.6|0.7|0.6|476|XI(b) Thyroid carcinomas|78112034|2003
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|58431001|2003
0-19|0.1|0.1|0.1|54|XI(c) Nasopharyngeal carcinomas|78112034|2003
0-19|0.0|0.1|0.1|44|XI(c) Nasopharyngeal carcinomas|79979457|2004
0-14|0.2|0.3|0.3|156|XI(d) Malignant melanomas|59678430|2004
0-19|0.6|0.7|0.7|532|XI(d) Malignant melanomas|79979457|2004
0-14|3.6|3.9|3.7|2189|I(a) Lymphoid leukemias|58268801|2006
0-19|3.1|3.3|3.2|2519|I(a) Lymphoid leukemias|78718627|2006
0-19|3.1|3.3|3.2|2519|I(a) Lymphoid leukemias|78718627|2006
0-19|0.1|0.1|0.1|54|XI(c) Nasopharyngeal carcinomas|78112034|2003
0-14|0.2|0.2|0.2|121|XI(d) Malignant melanomas|58431001|2003
0-19|0.6|0.7|0.6|474|XI(d) Malignant melanomas|78112034|2003
0-19|0.6|0.7|0.7|532|XI(d) Malignant melanomas|79979457|2004
0-14|~|~|~|~|XI(e) Skin carcinomas|59678430|2004
0-19|0.3|0.3|0.3|1143|VIII(c) Ewing tumor and related sarcomas of bone|408000943|2002-2006
0-14|0.0|0.0|0.0|85|VIII(d) Other specified malignant bone tumors|274499921|2002-2006
0-19|0.0|0.1|0.0|170|VIII(d) Other specified malignant bone tumors|368492797|2002-2006
0-14|0.7|0.8|0.7|440|I(b) Acute myeloid leukemias|58268801|2006
0-19|0.7|0.9|0.8|630|I(b) Acute myeloid leukemias|78718627|2006
0-19|0.7|0.9|0.8|630|I(b) Acute myeloid leukemias|78718627|2006
0-19|0.6|0.7|0.6|474|XI(d) Malignant melanomas|78112034|2003
0-19|~|~|~|~|XI(e) Skin carcinomas|79979457|2004
0-19|~|~|~|~|XI(e) Skin carcinomas|79979457|2004
0-19|0.0|0.1|0.0|187|VIII(d) Other specified malignant bone tumors|408000943|2002-2006
0-14|0.1|0.2|0.1|78|I(c) Chronic myeloproliferative diseases|58268801|2006
0-19|0.2|0.2|0.2|155|I(c) Chronic myeloproliferative diseases|78718627|2006
0-19|0.2|0.2|0.2|155|I(c) Chronic myeloproliferative diseases|78718627|2006
0-14|~|~|~|~|XI(e) Skin carcinomas|58431001|2003
0-19|~|~|~|~|XI(e) Skin carcinomas|78112034|2003
0-19|0.2|0.3|0.3|202|VIII(c) Ewing tumor and related sarcomas of bone|78112034|2003
0-14|0.1|0.2|0.2|96|XI(f) Other and unspecified carcinomas|59678430|2004
0-19|0.3|0.4|0.4|314|XI(f) Other and unspecified carcinomas|79979457|2004
0-19|0.4|0.4|0.4|314|XI(f) Other and unspecified carcinomas|79979457|2004
0-14|0.0|0.0|0.0|46|VIII(e) Unspecified malignant bone tumors|274499921|2002-2006
0-19|0.0|0.0|0.0|68|VIII(e) Unspecified malignant bone tumors|368492797|2002-2006
0-19|0.0|0.0|0.0|73|VIII(e) Unspecified malignant bone tumors|408000943|2002-2006
0-14|0.1|0.2|0.2|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58268801|2006
0-19|0.1|0.2|0.1|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78718627|2006
0-14|0.0|0.0|0.0|16|VIII(d) Other specified malignant bone tumors|58431001|2003
0-19|0.0|0.0|0.0|26|VIII(d) Other specified malignant bone tumors|78112034|2003
0-19|0.0|0.0|0.0|26|VIII(d) Other specified malignant bone tumors|78112034|2003
0-14|0.1|0.1|0.1|43|XII Other and unspecified malignant neoplasms|59678430|2004
0-19|0.1|0.1|0.1|67|XII Other and unspecified malignant neoplasms|79979457|2004
0-19|0.1|0.1|0.1|67|XII Other and unspecified malignant neoplasms|79979457|2004
0-14|0.5|0.6|0.5|1494|X Germ cell, trophoblastic tumors & neoplasms of gonads|274499921|2002-2006
0-19|1.1|1.1|1.1|4074|X Germ cell, trophoblastic tumors & neoplasms of gonads|368492797|2002-2006
0-19|1.1|1.2|1.1|4564|X Germ cell, trophoblastic tumors & neoplasms of gonads|408000943|2002-2006
0-19|0.1|0.2|0.2|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78718627|2006
0-14|0.1|0.2|0.1|78|I(e) Unspecified and other specified leukemias|58268801|2006
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|58431001|2003
0-19|0.0|0.0|0.0|17|VIII(e) Unspecified malignant bone tumors|78112034|2003
0-14|0.0|0.1|0.0|20|XII(a) Other specified malignant tumors|59678430|2004
0-19|0.0|0.1|0.0|31|XII(a) Other specified malignant tumors|79979457|2004
0-19|0.1|0.2|0.1|109|I(e) Unspecified and other specified leukemias|78718627|2006
0-19|0.1|0.2|0.1|109|I(e) Unspecified and other specified leukemias|78718627|2006
0-14|0.1|0.1|0.1|371|X(a) Intracranial & intraspinal germ cell tumors|274499921|2002-2006
0-19|0.1|0.2|0.2|585|X(a) Intracranial & intraspinal germ cell tumors|368492797|2002-2006
0-19|0.0|0.0|0.0|17|VIII(e) Unspecified malignant bone tumors|78112034|2003
0-14|0.5|0.6|0.5|304|X Germ cell, trophoblastic tumors & neoplasms of gonads|58431001|2003
0-19|1.0|1.1|1.0|805|X Germ cell, trophoblastic tumors & neoplasms of gonads|78112034|2003
0-19|1.1|1.2|1.1|902|X Germ cell, trophoblastic tumors & neoplasms of gonads|79979457|2004
0-14|~|~|~|~|VI(b) Renal carcinomas|56123816|2002
0-19|0.0|0.1|0.0|31|VI(b) Renal carcinomas|74939309|2002
0-19|0.0|0.1|0.0|31|VI(b) Renal carcinomas|74939309|2002
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|56123816|2002
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|74939309|2002
0-14|1.5|1.7|1.6|941|II Lymphomas and reticuloendothelial neoplasms|58268801|2006
0-19|2.3|2.6|2.5|1950|II Lymphomas and reticuloendothelial neoplasms|78718627|2006
0-19|2.4|2.6|2.5|1950|II Lymphomas and reticuloendothelial neoplasms|78718627|2006
0-19|0.2|0.2|0.2|668|X(a) Intracranial & intraspinal germ cell tumors|408000943|2002-2006
0-14|0.0|0.0|0.0|85|VI(b) Renal carcinomas|274499921|2002-2006
0-19|1.0|1.1|1.0|805|X Germ cell, trophoblastic tumors & neoplasms of gonads|78112034|2003
0-14|0.1|0.2|0.2|95|X(a) Intracranial & intraspinal germ cell tumors|59678430|2004
0-19|0.2|0.2|0.2|146|X(a) Intracranial & intraspinal germ cell tumors|79979457|2004
0-19|0.2|0.2|0.2|146|X(a) Intracranial & intraspinal germ cell tumors|79979457|2004
0-14|0.5|0.7|0.6|350|II(a) Hodgkin lymphomas|58268801|2006
0-19|1.2|1.3|1.2|991|II(a) Hodgkin lymphomas|78718627|2006
0-19|0.0|0.1|0.1|205|VI(b) Renal carcinomas|368492797|2002-2006
0-19|0.0|0.1|0.1|224|VI(b) Renal carcinomas|408000943|2002-2006
0-14|0.1|0.1|0.1|70|X(a) Intracranial & intraspinal germ cell tumors|58431001|2003
0-19|0.1|0.2|0.1|109|X(a) Intracranial & intraspinal germ cell tumors|78112034|2003
0-19|0.1|0.2|0.1|109|X(a) Intracranial & intraspinal germ cell tumors|78112034|2003
0-14|0.1|0.2|0.1|81|X(b) Malignant extracranial & extragonadal germ cell tumors|59678430|2004
0-19|0.1|0.2|0.1|106|X(b) Malignant extracranial & extragonadal germ cell tumors|79979457|2004
0-19|0.1|0.2|0.1|106|X(b) Malignant extracranial & extragonadal germ cell tumors|79979457|2004
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|74939309|2002
0-14|0.2|0.2|0.2|106|VII Hepatic tumors|56123816|2002
0-19|0.1|0.2|0.2|125|VII Hepatic tumors|74939309|2002
0-19|0.6|0.7|0.7|528|XI(d) Malignant melanomas|80201013|2005
0-14|~|~|~|~|XI(e) Skin carcinomas|59582794|2005
0-19|~|~|~|~|XI(e) Skin carcinomas|80201013|2005
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|274499921|2002-2006
0-19|0.0|0.0|0.0|16|VI(c) Unspecified malignant renal tumors|368492797|2002-2006
0-19|0.0|0.0|0.0|16|VI(c) Unspecified malignant renal tumors|408000943|2002-2006
0-19|1.1|1.2|1.2|874|IX Soft tissue and other extraosseous sarcomas|74878093|2001
0-14|0.4|0.6|0.5|278|IX(a) Rhabdomyosarcomas|56086557|2001
0-19|0.4|0.5|0.5|361|IX(a) Rhabdomyosarcomas|74878093|2001
0-14|0.1|0.2|0.1|87|X(b) Malignant extracranial & extragonadal germ cell tumors|58431001|2003
0-19|0.1|0.2|0.1|115|X(b) Malignant extracranial & extragonadal germ cell tumors|78112034|2003
0-19|0.1|0.2|0.1|115|X(b) Malignant extracranial & extragonadal germ cell tumors|78112034|2003
0-14|0.2|0.3|0.2|149|X(c) Malignant gonadal germ cell tumors|59678430|2004
0-19|0.7|0.8|0.7|595|X(c) Malignant gonadal germ cell tumors|79979457|2004
0-19|~|~|~|~|XI(e) Skin carcinomas|80201013|2005
0-14|0.2|0.2|0.2|115|XI(f) Other and unspecified carcinomas|59582794|2005
0-19|0.4|0.5|0.4|343|XI(f) Other and unspecified carcinomas|80201013|2005
0-14|0.2|0.3|0.2|673|VII Hepatic tumors|274499921|2002-2006
0-19|0.2|0.2|0.2|786|VII Hepatic tumors|368492797|2002-2006
0-19|0.2|0.2|0.2|874|VII Hepatic tumors|408000943|2002-2006
0-19|0.4|0.5|0.5|361|IX(a) Rhabdomyosarcomas|74878093|2001
0-14|0.1|0.2|0.1|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|56086557|2001
0-19|0.1|0.2|0.1|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74878093|2001
0-14|0.2|0.3|0.2|132|X(c) Malignant gonadal germ cell tumors|58431001|2003
0-19|0.6|0.7|0.7|527|X(c) Malignant gonadal germ cell tumors|78112034|2003
0-19|0.7|0.8|0.7|595|X(c) Malignant gonadal germ cell tumors|79979457|2004
0-14|~|~|~|~|X(d) Gonadal carcinomas|59678430|2004
0-19|0.0|0.1|0.0|31|X(d) Gonadal carcinomas|79979457|2004
0-19|0.1|0.2|0.2|125|VII Hepatic tumors|74939309|2002
0-14|0.1|0.2|0.2|86|VII(a) Hepatoblastoma|56123816|2002
0-19|0.1|0.1|0.1|87|VII(a) Hepatoblastoma|74939309|2002
0-19|0.4|0.5|0.4|343|XI(f) Other and unspecified carcinomas|80201013|2005
0-14|0.2|0.2|0.2|554|VII(a) Hepatoblastoma|274499921|2002-2006
0-19|0.1|0.2|0.1|556|VII(a) Hepatoblastoma|368492797|2002-2006
0-19|0.1|0.2|0.2|622|VII(a) Hepatoblastoma|408000943|2002-2006
0-19|0.1|0.2|0.1|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74878093|2001
0-19|0.6|0.7|0.7|527|X(c) Malignant gonadal germ cell tumors|78112034|2003
0-14|~|~|~|~|X(d) Gonadal carcinomas|58431001|2003
0-19|0.0|0.0|0.0|24|X(d) Gonadal carcinomas|78112034|2003
0-19|0.0|0.1|0.0|31|X(d) Gonadal carcinomas|79979457|2004
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59678430|2004
0-19|0.0|0.0|0.0|24|X(e) Other and unspecified malignant gonadal tumors|79979457|2004
0-14|0.0|0.1|0.1|36|XII Other and unspecified malignant neoplasms|59582794|2005
0-19|0.1|0.1|0.1|73|XII Other and unspecified malignant neoplasms|80201013|2005
0-19|0.1|0.1|0.1|73|XII Other and unspecified malignant neoplasms|80201013|2005
0-14|0.0|0.0|0.0|106|VII(b) Hepatic carcinomas|274499921|2002-2006
0-19|0.1|0.1|0.1|217|VII(b) Hepatic carcinomas|368492797|2002-2006
0-14|~|~|~|~|IX(c) Kaposi sarcoma|56086557|2001
0-19|~|~|~|~|IX(c) Kaposi sarcoma|74878093|2001
0-19|~|~|~|~|IX(c) Kaposi sarcoma|74878093|2001
0-19|0.1|0.1|0.1|87|VII(a) Hepatoblastoma|74939309|2002
0-14|0.0|0.1|0.0|19|VII(b) Hepatic carcinomas|56123816|2002
0-19|0.0|0.1|0.0|37|VII(b) Hepatic carcinomas|74939309|2002
0-14|0.2|0.3|0.3|148|III(a) Ependymomas and choroid plexus tumor|55173748|2000
0-19|0.2|0.3|0.2|170|III(a) Ependymomas and choroid plexus tumor|73649093|2000
0-19|0.2|0.3|0.2|170|III(a) Ependymomas and choroid plexus tumor|73649093|2000
0-14|0.2|0.3|0.3|149|VII Hepatic tumors|58431001|2003
0-19|0.2|0.2|0.2|170|VII Hepatic tumors|78112034|2003
0-19|0.2|0.3|0.2|170|VII Hepatic tumors|78112034|2003
0-19|0.0|0.0|0.0|24|X(e) Other and unspecified malignant gonadal tumors|79979457|2004
0-14|0.0|0.0|0.0|17|XII(a) Other specified malignant tumors|59582794|2005
0-19|0.0|0.1|0.0|30|XII(a) Other specified malignant tumors|80201013|2005
0-19|0.0|0.1|0.0|30|XII(a) Other specified malignant tumors|80201013|2005
0-19|0.1|0.1|0.1|239|VII(b) Hepatic carcinomas|408000943|2002-2006
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|274499921|2002-2006
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|368492797|2002-2006
0-14|0.3|0.3|0.3|170|IX(d) Other specified soft tissue sarcomas|56086557|2001
0-19|0.4|0.5|0.4|306|IX(d) Other specified soft tissue sarcomas|74878093|2001
0-19|2.8|3.1|2.9|2196|III CNS and misc intracranial and intraspinal neoplasms|74878093|2001
0-19|0.0|0.1|0.0|37|VII(b) Hepatic carcinomas|74939309|2002
0-14|0.2|0.2|0.2|122|VII(a) Hepatoblastoma|58431001|2003
0-19|0.1|0.2|0.2|122|VII(a) Hepatoblastoma|78112034|2003
0-19|0.1|0.2|0.2|122|VII(a) Hepatoblastoma|78112034|2003
0-14|1.6|1.8|1.7|920|III(b) Astrocytomas|55173748|2000
0-19|1.5|1.6|1.5|1140|III(b) Astrocytomas|73649093|2000
0-14|0.7|0.8|0.7|447|XI Other malignant epithelial neoplasms and malignant melanomas|59678430|2004
0-19|1.7|1.9|1.8|1454|XI Other malignant epithelial neoplasms and malignant melanomas|79979457|2004
0-19|1.7|1.9|1.8|1454|XI Other malignant epithelial neoplasms and malignant melanomas|79979457|2004
0-14|0.0|0.0|0.0|19|XII(b) Other unspecified malignant tumors|59582794|2005
0-19|0.0|0.1|0.1|43|XII(b) Other unspecified malignant tumors|80201013|2005
0-19|0.0|0.1|0.1|43|XII(b) Other unspecified malignant tumors|80201013|2005
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|408000943|2002-2006
0-14|0.7|0.7|0.7|1887|VIII Malignant bone tumors|274499921|2002-2006
0-19|1.1|1.3|1.2|885|IX Soft tissue and other extraosseous sarcomas|74939309|2002
0-14|0.5|0.6|0.5|302|IX(a) Rhabdomyosarcomas|56123816|2002
0-19|0.4|0.5|0.5|367|IX(a) Rhabdomyosarcomas|74939309|2002
0-14|0.2|0.3|0.3|154|III(a) Ependymomas and choroid plexus tumor|56086557|2001
0-19|0.2|0.3|0.2|179|III(a) Ependymomas and choroid plexus tumor|74878093|2001
0-14|0.0|0.1|0.0|27|VII(b) Hepatic carcinomas|58431001|2003
0-19|0.0|0.1|0.1|48|VII(b) Hepatic carcinomas|78112034|2003
0-19|0.0|0.1|0.1|48|VII(b) Hepatic carcinomas|78112034|2003
0-19|1.5|1.6|1.5|1140|III(b) Astrocytomas|73649093|2000
0-14|0.7|0.8|0.8|417|III(c) Intracranial and intraspinal embryonal tumors|55173748|2000
0-19|0.6|0.7|0.7|480|III(c) Intracranial and intraspinal embryonal tumors|73649093|2000
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|59678430|2004
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|79979457|2004
0-14|14.8|15.4|15.1|8864|All ICCC Groups Combined|58268801|2006
0-19|16.3|16.9|16.6|13186|All ICCC Groups Combined|78718627|2006
0-19|0.9|0.9|0.9|3315|VIII Malignant bone tumors|368492797|2002-2006
0-19|0.9|0.9|0.9|3659|VIII Malignant bone tumors|408000943|2002-2006
0-19|0.2|0.3|0.2|179|III(a) Ependymomas and choroid plexus tumor|74878093|2001
0-14|1.5|1.7|1.6|885|III(b) Astrocytomas|56086557|2001
0-19|1.4|1.6|1.5|1093|III(b) Astrocytomas|74878093|2001
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58431001|2003
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78112034|2003
0-19|0.6|0.7|0.7|480|III(c) Intracranial and intraspinal embryonal tumors|73649093|2000
0-14|0.4|0.5|0.4|246|III(d) Other gliomas|55173748|2000
0-19|0.4|0.5|0.4|321|III(d) Other gliomas|73649093|2000
0-14|0.6|0.8|0.7|426|VIII Malignant bone tumors|59678430|2004
0-19|0.8|1.0|0.9|723|VIII Malignant bone tumors|79979457|2004
0-19|16.5|17.0|16.8|13186|All ICCC Groups Combined|78718627|2006
0-14|4.7|5.1|4.9|2880|I Leukemias, myeloproliferative & myelodysplastic diseases|58268801|2006
0-19|4.3|4.6|4.5|3533|I Leukemias, myeloproliferative & myelodysplastic diseases|78718627|2006
0-19|0.4|0.5|0.5|367|IX(a) Rhabdomyosarcomas|74939309|2002
0-19|1.4|1.5|1.5|1093|III(b) Astrocytomas|74878093|2001
0-14|0.7|0.8|0.7|403|III(c) Intracranial and intraspinal embryonal tumors|56086557|2001
0-19|0.6|0.7|0.6|485|III(c) Intracranial and intraspinal embryonal tumors|74878093|2001
0-19|0.1|0.1|0.1|547|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|408000943|2002-2006
0-14|~|~|~|~|IX(c) Kaposi sarcoma|274499921|2002-2006
0-19|~|~|~|~|IX(c) Kaposi sarcoma|368492797|2002-2006
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78112034|2003
0-14|0.6|0.7|0.7|395|VIII Malignant bone tumors|58431001|2003
0-19|0.8|0.9|0.9|683|VIII Malignant bone tumors|78112034|2003
0-19|0.8|1.0|0.9|723|VIII Malignant bone tumors|79979457|2004
0-14|0.4|0.5|0.4|250|VIII(a) Osteosarcomas|59678430|2004
0-19|0.5|0.6|0.5|418|VIII(a) Osteosarcomas|79979457|2004
0-19|0.6|0.8|0.7|520|I(b) Acute myeloid leukemias|73649093|2000
0-19|0.7|0.8|0.7|608|X(c) Malignant gonadal germ cell tumors|80201013|2005
0-19|0.7|0.8|0.8|608|X(c) Malignant gonadal germ cell tumors|80201013|2005
0-14|0.1|0.2|0.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|56123816|2002
0-19|0.1|0.1|0.1|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74939309|2002
0-19|0.1|0.1|0.1|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74939309|2002
0-19|0.6|0.7|0.6|485|III(c) Intracranial and intraspinal embryonal tumors|74878093|2001
0-19|0.8|0.9|0.9|683|VIII Malignant bone tumors|78112034|2003
0-14|0.3|0.4|0.4|222|VIII(a) Osteosarcomas|58431001|2003
0-19|0.5|0.6|0.5|419|VIII(a) Osteosarcomas|78112034|2003
0-19|~|~|~|~|IX(c) Kaposi sarcoma|408000943|2002-2006
0-14|0.3|0.4|0.3|944|IX(d) Other specified soft tissue sarcomas|274499921|2002-2006
0-19|0.5|0.5|0.5|1778|IX(d) Other specified soft tissue sarcomas|368492797|2002-2006
0-19|0.5|0.6|0.5|418|VIII(a) Osteosarcomas|79979457|2004
0-14|0.0|0.0|0.0|17|VIII(b) Chondrosarcomas|59678430|2004
0-19|0.0|0.1|0.0|40|VIII(b) Chondrosarcomas|79979457|2004
0-14|0.1|0.1|0.1|42|I(c) Chronic myeloproliferative diseases|55173748|2000
0-19|0.1|0.1|0.1|65|I(c) Chronic myeloproliferative diseases|73649093|2000
0-19|0.1|0.1|0.1|65|I(c) Chronic myeloproliferative diseases|73649093|2000
0-14|~|~|~|~|X(d) Gonadal carcinomas|59582794|2005
0-19|0.0|0.1|0.0|31|X(d) Gonadal carcinomas|80201013|2005
0-19|0.0|0.1|0.0|31|X(d) Gonadal carcinomas|80201013|2005
0-14|0.5|0.6|0.5|297|III(d) Other gliomas|56086557|2001
0-19|0.4|0.5|0.5|369|III(d) Other gliomas|74878093|2001
0-19|0.4|0.5|0.5|369|III(d) Other gliomas|74878093|2001
0-19|0.5|0.6|0.5|419|VIII(a) Osteosarcomas|78112034|2003
0-14|~|~|~|~|VIII(b) Chondrosarcomas|58431001|2003
0-19|0.0|0.0|0.0|19|VIII(b) Chondrosarcomas|78112034|2003
0-19|0.5|0.5|0.5|1959|IX(d) Other specified soft tissue sarcomas|408000943|2002-2006
0-19|0.0|0.1|0.1|40|VIII(b) Chondrosarcomas|79979457|2004
0-14|0.2|0.3|0.2|137|VIII(c) Ewing tumor and related sarcomas of bone|59678430|2004
0-14|~|~|~|~|IX(c) Kaposi sarcoma|56123816|2002
0-19|~|~|~|~|IX(c) Kaposi sarcoma|74939309|2002
0-19|~|~|~|~|IX(c) Kaposi sarcoma|74939309|2002
0-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|55173748|2000
0-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|73649093|2000
0-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|73649093|2000
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59582794|2005
0-19|0.0|0.0|0.0|26|X(e) Other and unspecified malignant gonadal tumors|80201013|2005
0-14|0.0|0.1|0.1|36|III(e) Other specified intracranial & intraspinal neoplasms|56086557|2001
0-19|0.0|0.1|0.1|43|III(e) Other specified intracranial & intraspinal neoplasms|74878093|2001
0-19|0.0|0.1|0.1|43|III(e) Other specified intracranial & intraspinal neoplasms|74878093|2001
0-19|0.0|0.0|0.0|19|VIII(b) Chondrosarcomas|78112034|2003
0-19|0.2|0.3|0.3|215|VIII(c) Ewing tumor and related sarcomas of bone|79979457|2004
0-19|0.2|0.3|0.3|215|VIII(c) Ewing tumor and related sarcomas of bone|79979457|2004
0-14|0.1|0.1|0.1|260|IX(e) Unspecified soft tissue sarcomas|274499921|2002-2006
0-19|0.1|0.1|0.1|422|IX(e) Unspecified soft tissue sarcomas|368492797|2002-2006
0-19|0.1|0.1|0.1|459|IX(e) Unspecified soft tissue sarcomas|408000943|2002-2006
0-14|0.1|0.2|0.1|71|I(e) Unspecified and other specified leukemias|55173748|2000
0-19|0.1|0.2|0.1|94|I(e) Unspecified and other specified leukemias|73649093|2000
0-19|0.0|0.0|0.0|26|X(e) Other and unspecified malignant gonadal tumors|80201013|2005
0-14|0.6|0.8|0.7|413|XI Other malignant epithelial neoplasms and malignant melanomas|59582794|2005
0-19|1.7|1.8|1.7|1420|XI Other malignant epithelial neoplasms and malignant melanomas|80201013|2005
0-14|0.0|0.1|0.0|19|III(f) Unspecified intracranial and intraspinal neoplasms|56086557|2001
0-19|0.0|0.1|0.0|27|III(f) Unspecified intracranial and intraspinal neoplasms|74878093|2001
0-19|0.1|0.1|0.1|73|XII Other and unspecified malignant neoplasms|78718627|2006
0-14|0.0|0.1|0.0|26|XII(a) Other specified malignant tumors|58268801|2006
0-19|0.0|0.1|0.0|39|XII(a) Other specified malignant tumors|78718627|2006
0-14|0.2|0.3|0.2|131|VIII(c) Ewing tumor and related sarcomas of bone|58431001|2003
0-19|0.2|0.3|0.3|202|VIII(c) Ewing tumor and related sarcomas of bone|78112034|2003
0-14|0.0|0.0|0.0|85|Not classified by ICCC|274499921|2002-2006
0-19|0.0|0.0|0.0|130|Not classified by ICCC|368492797|2002-2006
0-19|0.0|0.0|0.0|140|Not classified by ICCC|408000943|2002-2006
0-14|0.0|0.0|0.0|17|VIII(d) Other specified malignant bone tumors|59678430|2004
0-19|0.0|0.1|0.0|37|VIII(d) Other specified malignant bone tumors|79979457|2004
0-19|0.0|0.1|0.0|37|VIII(d) Other specified malignant bone tumors|79979457|2004
0-19|0.1|0.2|0.1|94|I(e) Unspecified and other specified leukemias|73649093|2000
0-14|1.5|1.8|1.6|908|II Lymphomas and reticuloendothelial neoplasms|55173748|2000
0-19|2.4|2.6|2.5|1819|II Lymphomas and reticuloendothelial neoplasms|73649093|2000
0-19|1.7|1.9|1.8|1420|XI Other malignant epithelial neoplasms and malignant melanomas|80201013|2005
0-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|53943757|1999
0-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|71920580|1999
0-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|71920580|1999
0-19|0.0|0.1|0.0|27|III(f) Unspecified intracranial and intraspinal neoplasms|74878093|2001
0-14|1.1|1.3|1.2|658|IV Neuroblastoma and other peripheral nervous cell tumors|56086557|2001
0-19|0.8|1.0|0.9|672|IV Neuroblastoma and other peripheral nervous cell tumors|74878093|2001
0-19|0.0|0.1|0.0|39|XII(a) Other specified malignant tumors|78718627|2006
0-14|0.1|0.1|0.1|59|IX(e) Unspecified soft tissue sarcomas|58431001|2003
0-19|0.1|0.2|0.1|99|IX(e) Unspecified soft tissue sarcomas|78112034|2003
0-19|0.1|0.2|0.1|99|IX(e) Unspecified soft tissue sarcomas|78112034|2003
0-14|0.4|0.4|0.4|1093|V Retinoblastoma|274499921|2002-2006
0-19|0.3|0.3|0.3|1098|V Retinoblastoma|368492797|2002-2006
0-19|0.3|0.3|0.3|1263|V Retinoblastoma|408000943|2002-2006
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|59678430|2004
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|79979457|2004
0-19|2.4|2.6|2.5|1819|II Lymphomas and reticuloendothelial neoplasms|73649093|2000
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|59582794|2005
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|80201013|2005
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|80201013|2005
0-19|0.1|0.1|0.1|90|I(e) Unspecified and other specified leukemias|74878093|2001
0-14|0.0|0.1|0.0|19|XII(b) Other unspecified malignant tumors|58268801|2006
0-19|0.0|0.1|0.0|34|XII(b) Other unspecified malignant tumors|78718627|2006
0-19|0.0|0.1|0.0|34|XII(b) Other unspecified malignant tumors|78718627|2006
0-14|0.1|0.2|0.1|74|I(e) Unspecified and other specified leukemias|53943757|1999
0-19|0.1|0.2|0.1|94|I(e) Unspecified and other specified leukemias|71920580|1999
0-19|0.1|0.2|0.1|94|I(e) Unspecified and other specified leukemias|71920580|1999
0-14|0.0|0.0|0.0|17|Not classified by ICCC|58431001|2003
0-19|0.0|0.0|0.0|25|Not classified by ICCC|78112034|2003
0-19|0.0|0.0|0.0|25|Not classified by ICCC|78112034|2003
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|79979457|2004
0-14|0.5|0.6|0.6|342|X Germ cell, trophoblastic tumors & neoplasms of gonads|59678430|2004
0-19|1.0|1.2|1.1|902|X Germ cell, trophoblastic tumors & neoplasms of gonads|79979457|2004
0-14|0.8|0.9|0.8|2279|VI Renal tumors|274499921|2002-2006
0-19|0.6|0.7|0.7|2432|VI Renal tumors|368492797|2002-2006
0-14|0.5|0.6|0.6|321|II(a) Hodgkin lymphomas|55173748|2000
0-19|1.1|1.3|1.2|896|II(a) Hodgkin lymphomas|73649093|2000
0-19|1.1|1.3|1.2|896|II(a) Hodgkin lymphomas|73649093|2000
0-14|0.3|0.4|0.3|191|IX(d) Other specified soft tissue sarcomas|56123816|2002
0-19|0.4|0.5|0.5|354|IX(d) Other specified soft tissue sarcomas|74939309|2002
0-14|0.2|0.3|0.2|129|XI(b) Thyroid carcinomas|59582794|2005
0-19|0.6|0.7|0.6|498|XI(b) Thyroid carcinomas|80201013|2005
0-19|0.6|0.7|0.6|498|XI(b) Thyroid carcinomas|80201013|2005
0-14|1.5|1.7|1.6|903|II Lymphomas and reticuloendothelial neoplasms|56086557|2001
0-19|2.3|2.6|2.4|1832|II Lymphomas and reticuloendothelial neoplasms|74878093|2001
0-19|2.3|2.6|2.4|1832|II Lymphomas and reticuloendothelial neoplasms|74878093|2001
0-14|0.3|0.4|0.4|230|V Retinoblastoma|58431001|2003
0-19|0.3|0.3|0.3|232|V Retinoblastoma|78112034|2003
0-19|0.3|0.3|0.3|232|V Retinoblastoma|78112034|2003
0-14|1.4|1.7|1.5|834|II Lymphomas and reticuloendothelial neoplasms|53943757|1999
0-19|2.2|2.4|2.3|1673|II Lymphomas and reticuloendothelial neoplasms|71920580|1999
0-14|0.7|0.9|0.8|488|VI Renal tumors|59678430|2004
0-19|0.6|0.7|0.6|521|VI Renal tumors|79979457|2004
0-19|0.6|0.7|0.7|521|VI Renal tumors|79979457|2004
0-19|0.6|0.7|0.7|2659|VI Renal tumors|408000943|2002-2006
0-14|0.8|0.8|0.8|2181|VI(a) Nephroblastoma and other nonepithelial renal tumors|274499921|2002-2006
0-19|0.6|0.6|0.6|2211|VI(a) Nephroblastoma and other nonepithelial renal tumors|368492797|2002-2006
0-14|0.5|0.7|0.6|323|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|55173748|2000
0-19|0.7|0.9|0.8|598|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|73649093|2000
0-19|0.7|0.9|0.8|598|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|73649093|2000
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|59582794|2005
0-19|0.0|0.1|0.0|33|XI(c) Nasopharyngeal carcinomas|80201013|2005
0-19|0.0|0.1|0.0|33|XI(c) Nasopharyngeal carcinomas|80201013|2005
0-19|0.4|0.5|0.5|354|IX(d) Other specified soft tissue sarcomas|74939309|2002
0-14|0.1|0.1|0.1|53|IX(e) Unspecified soft tissue sarcomas|56123816|2002
0-19|0.1|0.1|0.1|74|IX(e) Unspecified soft tissue sarcomas|74939309|2002
0-14|0.5|0.7|0.6|334|II(a) Hodgkin lymphomas|56086557|2001
0-19|1.2|1.3|1.2|930|II(a) Hodgkin lymphomas|74878093|2001
0-19|1.2|1.3|1.2|930|II(a) Hodgkin lymphomas|74878093|2001
0-14|0.8|0.9|0.8|485|VI Renal tumors|58431001|2003
0-19|0.6|0.7|0.7|509|VI Renal tumors|78112034|2003
0-19|0.6|0.7|0.7|509|VI Renal tumors|78112034|2003
0-14|0.7|0.8|0.8|466|VI(a) Nephroblastoma and other nonepithelial renal tumors|59678430|2004
0-19|0.5|0.6|0.6|474|VI(a) Nephroblastoma and other nonepithelial renal tumors|79979457|2004
0-19|0.6|0.6|0.6|2419|VI(a) Nephroblastoma and other nonepithelial renal tumors|408000943|2002-2006
0-14|0.0|0.1|0.1|138|III(f) Unspecified intracranial and intraspinal neoplasms|274499921|2002-2006
0-19|0.0|0.1|0.0|178|III(f) Unspecified intracranial and intraspinal neoplasms|368492797|2002-2006
0-14|0.2|0.3|0.3|157|II(c) Burkitt lymphoma|55173748|2000
0-19|0.2|0.3|0.3|200|II(c) Burkitt lymphoma|73649093|2000
0-14|0.2|0.3|0.2|146|XI(d) Malignant melanomas|59582794|2005
0-19|0.6|0.7|0.6|528|XI(d) Malignant melanomas|80201013|2005
0-19|0.0|0.0|0.0|20|VIII(b) Chondrosarcomas|80201013|2005
0-19|0.1|0.1|0.1|74|IX(e) Unspecified soft tissue sarcomas|74939309|2002
0-14|0.0|0.1|0.0|24|Not classified by ICCC|56123816|2002
0-19|0.0|0.1|0.0|28|Not classified by ICCC|74939309|2002
0-14|0.6|0.7|0.7|371|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|56086557|2001
0-19|0.8|0.9|0.9|653|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74878093|2001
0-19|0.8|0.9|0.9|653|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74878093|2001
0-14|0.7|0.9|0.8|462|VI(a) Nephroblastoma and other nonepithelial renal tumors|58431001|2003
0-19|0.5|0.6|0.6|464|VI(a) Nephroblastoma and other nonepithelial renal tumors|78112034|2003
0-19|0.5|0.6|0.6|474|VI(a) Nephroblastoma and other nonepithelial renal tumors|79979457|2004
0-14|0.0|0.1|0.0|21|VI(b) Renal carcinomas|59678430|2004
0-19|0.0|0.1|0.1|45|VI(b) Renal carcinomas|79979457|2004
0-19|0.0|0.1|0.0|181|III(f) Unspecified intracranial and intraspinal neoplasms|408000943|2002-2006
0-19|0.3|0.4|0.4|272|XI(f) Other and unspecified carcinomas|71920580|1999
0-14|0.0|0.1|0.0|26|XII Other and unspecified malignant neoplasms|53943757|1999
0-19|0.1|0.1|0.1|52|XII Other and unspecified malignant neoplasms|71920580|1999
0-14|0.2|0.3|0.2|143|VIII(c) Ewing tumor and related sarcomas of bone|59582794|2005
0-19|0.3|0.3|0.3|237|VIII(c) Ewing tumor and related sarcomas of bone|80201013|2005
0-14|0.2|0.3|0.2|125|II(c) Burkitt lymphoma|56086557|2001
0-19|0.2|0.2|0.2|160|II(c) Burkitt lymphoma|74878093|2001
0-19|0.5|0.7|0.6|464|VI(a) Nephroblastoma and other nonepithelial renal tumors|78112034|2003
0-14|0.0|0.1|0.0|19|VI(b) Renal carcinomas|58431001|2003
0-19|0.0|0.1|0.1|41|VI(b) Renal carcinomas|78112034|2003
0-19|0.0|0.1|0.1|45|VI(b) Renal carcinomas|79979457|2004
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|59678430|2004
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|79979457|2004
0-19|0.0|0.1|0.0|28|Not classified by ICCC|74939309|2002
0-14|0.3|0.4|0.4|209|V Retinoblastoma|56123816|2002
0-14|1.0|1.1|1.1|2987|IV Neuroblastoma and other peripheral nervous cell tumors|274499921|2002-2006
0-19|0.8|0.8|0.8|3057|IV Neuroblastoma and other peripheral nervous cell tumors|368492797|2002-2006
0-19|0.8|0.9|0.8|3353|IV Neuroblastoma and other peripheral nervous cell tumors|408000943|2002-2006
0-19|0.1|0.1|0.1|52|XII Other and unspecified malignant neoplasms|71920580|1999
0-14|~|~|~|~|XII(a) Other specified malignant tumors|53943757|1999
0-19|0.2|0.2|0.2|160|II(c) Burkitt lymphoma|74878093|2001
0-14|0.1|0.1|0.1|54|II(d) Miscellaneous lymphoreticular neoplasms|56086557|2001
0-19|0.1|0.1|0.1|56|II(d) Miscellaneous lymphoreticular neoplasms|74878093|2001
0-19|~|~|~|~|XII(a) Other specified malignant tumors|71920580|1999
0-19|~|~|~|~|XII(a) Other specified malignant tumors|71920580|1999
0-19|0.1|0.1|0.1|56|II(d) Miscellaneous lymphoreticular neoplasms|74878093|2001
0-14|0.0|0.1|0.0|19|II(e) Unspecified lymphomas|56086557|2001
0-19|0.0|0.1|0.0|33|II(e) Unspecified lymphomas|74878093|2001
0-19|0.3|0.3|0.3|237|VIII(c) Ewing tumor and related sarcomas of bone|80201013|2005
0-14|0.0|0.0|0.0|19|VIII(d) Other specified malignant bone tumors|59582794|2005
0-19|0.0|0.1|0.0|35|VIII(d) Other specified malignant bone tumors|80201013|2005
0-19|0.0|0.1|0.0|35|VIII(d) Other specified malignant bone tumors|80201013|2005
0-19|0.0|0.1|0.0|33|II(e) Unspecified lymphomas|74878093|2001
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|59582794|2005
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|80201013|2005
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|80201013|2005
0-14|0.5|0.6|0.5|328|X Germ cell, trophoblastic tumors & neoplasms of gonads|59582794|2005
0-19|1.1|1.2|1.1|919|X Germ cell, trophoblastic tumors & neoplasms of gonads|80201013|2005
0-19|1.1|1.2|1.1|919|X Germ cell, trophoblastic tumors & neoplasms of gonads|80201013|2005
0-14|0.1|0.2|0.1|80|X(a) Intracranial & intraspinal germ cell tumors|59582794|2005
0-19|0.1|0.2|0.2|125|X(a) Intracranial & intraspinal germ cell tumors|80201013|2005
0-19|0.1|0.2|0.2|125|X(a) Intracranial & intraspinal germ cell tumors|80201013|2005
0-14|0.1|0.2|0.2|96|X(b) Malignant extracranial & extragonadal germ cell tumors|59582794|2005
0-19|0.1|0.2|0.2|129|X(b) Malignant extracranial & extragonadal germ cell tumors|80201013|2005
0-19|0.1|0.2|0.2|129|X(b) Malignant extracranial & extragonadal germ cell tumors|80201013|2005
0-14|0.7|0.8|0.7|429|XI Other malignant epithelial neoplasms and malignant melanomas|58268801|2006
0-19|1.6|1.8|1.7|1372|XI Other malignant epithelial neoplasms and malignant melanomas|78718627|2006
0-14|0.0|0.1|0.0|17|XII(b) Other unspecified malignant tumors|53943757|1999
0-19|0.0|0.1|0.1|38|XII(b) Other unspecified malignant tumors|71920580|1999
0-19|0.0|0.1|0.1|38|XII(b) Other unspecified malignant tumors|71920580|1999
0-19|0.0|0.1|0.1|41|VI(b) Renal carcinomas|78112034|2003
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|58431001|2003
0-14|0.2|0.3|0.2|136|X(c) Malignant gonadal germ cell tumors|59582794|2005
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|59582794|2005
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|80201013|2005
0-14|1.0|1.1|1.1|2948|IV(a) Neuroblastoma and ganglioneuroblastoma|274499921|2002-2006
0-19|0.8|0.8|0.8|2986|IV(a) Neuroblastoma and ganglioneuroblastoma|368492797|2002-2006
0-19|0.8|0.8|0.8|3274|IV(a) Neuroblastoma and ganglioneuroblastoma|408000943|2002-2006
0-14|3.1|3.4|3.2|1794|III CNS and misc intracranial and intraspinal neoplasms|56086557|2001
0-19|2.8|3.1|2.9|2196|III CNS and misc intracranial and intraspinal neoplasms|74878093|2001
0-19|0.0|0.1|0.0|31|XII(b) Other unspecified malignant tumors|73649093|2000
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|79979457|2004
0-14|0.0|0.0|0.0|39|IV(b) Other peripheral nervous cell tumors|274499921|2002-2006
0-19|0.0|0.0|0.0|71|IV(b) Other peripheral nervous cell tumors|368492797|2002-2006
0-19|1.7|1.8|1.7|1372|XI Other malignant epithelial neoplasms and malignant melanomas|78718627|2006
0-14|14.5|15.1|14.8|8142|All ICCC Groups Combined|55173748|2000
0-19|15.9|16.5|16.2|11905|All ICCC Groups Combined|73649093|2000
0-19|15.9|16.5|16.2|11905|All ICCC Groups Combined|73649093|2000
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|80201013|2005
0-14|0.2|0.3|0.2|140|VII Hepatic tumors|59582794|2005
0-19|0.2|0.2|0.2|161|VII Hepatic tumors|80201013|2005
0-14|15.2|15.9|15.5|8703|All ICCC Groups Combined|56086557|2001
0-19|16.6|17.2|16.9|12658|All ICCC Groups Combined|74878093|2001
0-19|16.6|17.2|16.9|12658|All ICCC Groups Combined|74878093|2001
0-19|0.2|0.2|0.2|161|VII Hepatic tumors|80201013|2005
0-14|0.1|0.2|0.2|112|VII(a) Hepatoblastoma|59582794|2005
0-19|0.1|0.2|0.1|113|VII(a) Hepatoblastoma|80201013|2005
0-19|0.0|0.0|0.0|79|IV(b) Other peripheral nervous cell tumors|408000943|2002-2006
0-14|1.0|1.1|1.1|2899|IX Soft tissue and other extraosseous sarcomas|274499921|2002-2006
0-19|1.2|1.2|1.2|4424|IX Soft tissue and other extraosseous sarcomas|368492797|2002-2006
0-19|0.1|0.2|0.1|113|VII(a) Hepatoblastoma|80201013|2005
0-14|0.0|0.1|0.0|26|VII(b) Hepatic carcinomas|59582794|2005
0-19|0.0|0.1|0.1|46|VII(b) Hepatic carcinomas|80201013|2005
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|58268801|2006
0-19|0.0|0.0|0.0|16|XI(a) Adrenocortical carcinomas|78718627|2006
0-19|0.0|0.0|0.0|16|XI(a) Adrenocortical carcinomas|78718627|2006
0-19|1.2|1.2|1.2|4885|IX Soft tissue and other extraosseous sarcomas|408000943|2002-2006
0-19|0.0|0.1|0.1|46|VII(b) Hepatic carcinomas|80201013|2005
0-14|4.9|5.2|5.1|2824|I Leukemias, myeloproliferative & myelodysplastic diseases|56086557|2001
0-19|4.4|4.7|4.6|3404|I Leukemias, myeloproliferative & myelodysplastic diseases|74878093|2001
0-14|0.2|0.3|0.3|149|XI(b) Thyroid carcinomas|58268801|2006
0-19|0.6|0.7|0.7|535|XI(b) Thyroid carcinomas|78718627|2006
0-19|0.6|0.7|0.7|535|XI(b) Thyroid carcinomas|78718627|2006
0-14|0.5|0.5|0.5|1378|IX(a) Rhabdomyosarcomas|274499921|2002-2006
0-19|0.4|0.5|0.5|1726|IX(a) Rhabdomyosarcomas|368492797|2002-2006
0-19|0.4|0.5|0.5|1905|IX(a) Rhabdomyosarcomas|408000943|2002-2006
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59582794|2005
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80201013|2005
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|80201013|2005
0-14|4.4|4.8|4.6|2520|I Leukemias, myeloproliferative & myelodysplastic diseases|55173748|2000
0-19|4.0|4.3|4.1|3030|I Leukemias, myeloproliferative & myelodysplastic diseases|73649093|2000
0-19|4.4|4.7|4.5|3404|I Leukemias, myeloproliferative & myelodysplastic diseases|74878093|2001
0-14|3.7|4.1|3.9|2168|I(a) Lymphoid leukemias|56086557|2001
0-19|3.2|3.5|3.3|2471|I(a) Lymphoid leukemias|74878093|2001
0-14|0.1|0.1|0.1|309|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|274499921|2002-2006
0-19|0.1|0.1|0.1|485|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|368492797|2002-2006
0-14|0.0|0.1|0.0|19|XI(c) Nasopharyngeal carcinomas|58268801|2006
0-19|0.0|0.1|0.1|52|XI(c) Nasopharyngeal carcinomas|78718627|2006
0-19|0.0|0.1|0.1|52|XI(c) Nasopharyngeal carcinomas|78718627|2006
0-14|0.2|0.3|0.3|162|VII Hepatic tumors|59678430|2004
0-19|0.2|0.3|0.2|194|VII Hepatic tumors|79979457|2004
0-19|0.2|0.3|0.2|194|VII Hepatic tumors|79979457|2004
0-14|0.6|0.7|0.7|400|VIII Malignant bone tumors|59582794|2005
0-19|0.8|0.9|0.9|704|VIII Malignant bone tumors|80201013|2005
0-19|0.8|0.9|0.9|704|VIII Malignant bone tumors|80201013|2005
0-19|3.2|3.4|3.3|2471|I(a) Lymphoid leukemias|74878093|2001
0-19|4.0|4.3|4.1|3030|I Leukemias, myeloproliferative & myelodysplastic diseases|73649093|2000
0-14|3.5|3.9|3.7|2037|I(a) Lymphoid leukemias|55173748|2000
0-19|3.1|3.3|3.2|2342|I(a) Lymphoid leukemias|73649093|2000
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|78112034|2003
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|78112034|2003
0-14|0.0|0.0|0.0|57|II(e) Unspecified lymphomas|274499921|2002-2006
0-19|0.0|0.0|0.0|116|II(e) Unspecified lymphomas|368492797|2002-2006
0-19|0.0|0.0|0.0|122|II(e) Unspecified lymphomas|408000943|2002-2006
0-14|0.2|0.3|0.2|140|XI(d) Malignant melanomas|58268801|2006
0-19|0.5|0.6|0.5|436|XI(d) Malignant melanomas|78718627|2006
0-14|0.3|0.4|0.4|220|VIII(a) Osteosarcomas|59582794|2005
0-19|0.4|0.5|0.5|398|VIII(a) Osteosarcomas|80201013|2005
0-19|0.4|0.5|0.5|398|VIII(a) Osteosarcomas|80201013|2005
0-14|0.7|0.8|0.7|411|I(b) Acute myeloid leukemias|56086557|2001
0-19|0.7|0.8|0.8|573|I(b) Acute myeloid leukemias|74878093|2001
0-19|0.7|0.8|0.8|573|I(b) Acute myeloid leukemias|74878093|2001
0-19|3.1|3.3|3.2|2342|I(a) Lymphoid leukemias|73649093|2000
0-14|0.6|0.7|0.7|362|I(b) Acute myeloid leukemias|55173748|2000
0-19|0.6|0.8|0.7|520|I(b) Acute myeloid leukemias|73649093|2000
0-14|0.2|0.3|0.2|142|VII(a) Hepatoblastoma|59678430|2004
0-19|0.1|0.2|0.2|142|VII(a) Hepatoblastoma|79979457|2004
0-19|0.1|0.2|0.2|142|VII(a) Hepatoblastoma|79979457|2004
0-14|0.9|1.1|1.0|605|IV(a) Neuroblastoma and ganglioneuroblastoma|58431001|2003
0-19|0.7|0.8|0.8|616|IV(a) Neuroblastoma and ganglioneuroblastoma|78112034|2003
0-19|0.2|0.3|0.3|209|V Retinoblastoma|74939309|2002
0-19|0.6|0.7|0.6|477|III(c) Intracranial and intraspinal embryonal tumors|74939309|2002
0-14|3.2|3.3|3.3|8930|III CNS and misc intracranial and intraspinal neoplasms|274499921|2002-2006
0-19|2.9|3.0|3.0|10988|III CNS and misc intracranial and intraspinal neoplasms|368492797|2002-2006
0-19|2.9|3.0|3.0|12061|III CNS and misc intracranial and intraspinal neoplasms|408000943|2002-2006
0-19|0.5|0.6|0.6|436|XI(d) Malignant melanomas|78718627|2006
0-14|~|~|~|~|XI(e) Skin carcinomas|58268801|2006
0-19|~|~|~|~|XI(e) Skin carcinomas|78718627|2006
0-14|~|~|~|~|VIII(b) Chondrosarcomas|59582794|2005
0-19|0.0|0.0|0.0|20|VIII(b) Chondrosarcomas|80201013|2005
0-19|~|~|~|~|IX(c) Kaposi sarcoma|80201013|2005
0-14|0.1|0.2|0.2|91|I(c) Chronic myeloproliferative diseases|56086557|2001
0-19|0.2|0.2|0.2|156|I(c) Chronic myeloproliferative diseases|74878093|2001
0-19|0.2|0.2|0.2|156|I(c) Chronic myeloproliferative diseases|74878093|2001
0-14|~|~|~|~|VII(b) Hepatic carcinomas|59678430|2004
0-19|0.0|0.1|0.1|47|VII(b) Hepatic carcinomas|79979457|2004
0-19|0.0|0.1|0.1|47|VII(b) Hepatic carcinomas|79979457|2004
0-19|0.7|0.9|0.8|616|IV(a) Neuroblastoma and ganglioneuroblastoma|78112034|2003
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|58431001|2003
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|78112034|2003
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|53943757|1999
0-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|71920580|1999
0-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|71920580|1999
0-14|0.3|0.3|0.3|830|III(a) Ependymomas and choroid plexus tumor|274499921|2002-2006
0-19|0.3|0.3|0.3|996|III(a) Ependymomas and choroid plexus tumor|368492797|2002-2006
0-19|~|~|~|~|XI(e) Skin carcinomas|78718627|2006
0-14|0.1|0.2|0.2|104|XI(f) Other and unspecified carcinomas|58268801|2006
0-19|0.4|0.5|0.4|330|XI(f) Other and unspecified carcinomas|78718627|2006
0-14|0.3|0.4|0.3|193|IX(d) Other specified soft tissue sarcomas|59582794|2005
0-19|0.4|0.5|0.5|389|IX(d) Other specified soft tissue sarcomas|80201013|2005
0-19|0.4|0.5|0.5|389|IX(d) Other specified soft tissue sarcomas|80201013|2005
0-14|0.1|0.2|0.2|91|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|56086557|2001
0-19|0.1|0.2|0.2|114|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74878093|2001
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59678430|2004
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|79979457|2004
0-19|1.1|1.3|1.2|961|IX Soft tissue and other extraosseous sarcomas|79979457|2004
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|78112034|2003
0-14|0.5|0.6|0.6|325|III(d) Other gliomas|56123816|2002
0-19|0.5|0.6|0.5|406|III(d) Other gliomas|74939309|2002
0-19|0.5|0.6|0.5|406|III(d) Other gliomas|74939309|2002
0-14|0.5|0.7|0.6|312|XI Other malignant epithelial neoplasms and malignant melanomas|53943757|1999
0-19|1.4|1.6|1.5|1089|XI Other malignant epithelial neoplasms and malignant melanomas|71920580|1999
0-19|0.3|0.3|0.3|1108|III(a) Ependymomas and choroid plexus tumor|408000943|2002-2006
0-14|1.5|1.6|1.6|4307|III(b) Astrocytomas|274499921|2002-2006
0-19|1.4|1.5|1.5|5451|III(b) Astrocytomas|368492797|2002-2006
0-19|0.4|0.5|0.4|330|XI(f) Other and unspecified carcinomas|78718627|2006
0-14|0.1|0.1|0.1|47|IX(e) Unspecified soft tissue sarcomas|59582794|2005
0-19|0.1|0.1|0.1|87|IX(e) Unspecified soft tissue sarcomas|80201013|2005
0-19|0.1|0.2|0.2|114|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74878093|2001
0-14|0.1|0.1|0.1|63|I(e) Unspecified and other specified leukemias|56086557|2001
0-19|0.1|0.1|0.1|90|I(e) Unspecified and other specified leukemias|74878093|2001
0-14|0.4|0.5|0.5|281|IX(a) Rhabdomyosarcomas|59678430|2004
0-19|0.4|0.5|0.4|349|IX(a) Rhabdomyosarcomas|79979457|2004
0-19|0.4|0.5|0.4|349|IX(a) Rhabdomyosarcomas|79979457|2004
0-14|1.0|1.1|1.1|625|IX Soft tissue and other extraosseous sarcomas|58431001|2003
0-19|1.1|1.3|1.2|954|IX Soft tissue and other extraosseous sarcomas|78112034|2003
0-19|1.1|1.3|1.2|954|IX Soft tissue and other extraosseous sarcomas|78112034|2003
0-19|1.4|1.6|1.5|1089|XI Other malignant epithelial neoplasms and malignant melanomas|71920580|1999
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|53943757|1999
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|71920580|1999
0-19|1.4|1.5|1.5|5971|III(b) Astrocytomas|408000943|2002-2006
0-14|0.7|0.8|0.7|1998|III(c) Intracranial and intraspinal embryonal tumors|274499921|2002-2006
0-19|0.6|0.6|0.6|2253|III(c) Intracranial and intraspinal embryonal tumors|368492797|2002-2006
0-14|0.1|0.1|0.1|45|XII Other and unspecified malignant neoplasms|58268801|2006
0-19|0.1|0.1|0.1|73|XII Other and unspecified malignant neoplasms|78718627|2006
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|78718627|2006
0-19|15.6|16.2|15.9|11401|All ICCC Groups Combined|71920580|1999
0-14|14.3|14.9|14.6|7852|All ICCC Groups Combined|53943757|1999
0-19|0.1|0.1|0.1|87|IX(e) Unspecified soft tissue sarcomas|80201013|2005
0-14|0.0|0.1|0.0|21|Not classified by ICCC|59582794|2005
0-19|0.0|0.0|0.0|28|Not classified by ICCC|80201013|2005
0-14|0.1|0.2|0.2|100|XI(b) Thyroid carcinomas|55173748|2000
0-19|0.5|0.6|0.5|404|XI(b) Thyroid carcinomas|73649093|2000
0-19|0.5|0.6|0.5|404|XI(b) Thyroid carcinomas|73649093|2000
0-14|0.1|0.2|0.1|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59678430|2004
0-19|0.1|0.2|0.1|105|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|79979457|2004
0-14|0.5|0.6|0.5|303|IX(a) Rhabdomyosarcomas|58431001|2003
0-19|0.4|0.5|0.5|383|IX(a) Rhabdomyosarcomas|78112034|2003
0-19|0.4|0.5|0.5|383|IX(a) Rhabdomyosarcomas|78112034|2003
0-19|~|~|~|~|XI(a) Adrenocortical carcinomas|71920580|1999
0-14|0.1|0.1|0.1|40|III(e) Other specified intracranial & intraspinal neoplasms|56123816|2002
0-19|0.1|0.1|0.1|54|III(e) Other specified intracranial & intraspinal neoplasms|74939309|2002
0-19|0.1|0.1|0.1|54|III(e) Other specified intracranial & intraspinal neoplasms|74939309|2002
0-14|0.4|0.6|0.5|290|X Germ cell, trophoblastic tumors & neoplasms of gonads|58268801|2006
0-19|0.9|1.1|1.0|793|X Germ cell, trophoblastic tumors & neoplasms of gonads|78718627|2006
0-19|0.0|0.1|0.0|28|Not classified by ICCC|80201013|2005
0-14|0.3|0.4|0.4|226|V Retinoblastoma|59582794|2005
0-19|0.2|0.3|0.3|228|V Retinoblastoma|80201013|2005
0-19|0.6|0.6|0.6|2487|III(c) Intracranial and intraspinal embryonal tumors|408000943|2002-2006
0-14|0.0|0.1|0.0|19|XI(c) Nasopharyngeal carcinomas|55173748|2000
0-19|0.0|0.1|0.1|40|XI(c) Nasopharyngeal carcinomas|73649093|2000
0-19|0.0|0.1|0.1|40|XI(c) Nasopharyngeal carcinomas|73649093|2000
0-19|0.1|0.2|0.1|105|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|79979457|2004
0-14|~|~|~|~|IX(c) Kaposi sarcoma|59678430|2004
0-19|~|~|~|~|IX(c) Kaposi sarcoma|79979457|2004
0-14|0.1|0.1|0.1|58|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58431001|2003
0-19|0.1|0.2|0.1|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78112034|2003
0-14|0.2|0.2|0.2|103|XI(b) Thyroid carcinomas|53943757|1999
0-19|0.5|0.6|0.6|422|XI(b) Thyroid carcinomas|71920580|1999
0-19|0.5|0.6|0.6|422|XI(b) Thyroid carcinomas|71920580|1999
0-19|0.9|1.1|1.0|793|X Germ cell, trophoblastic tumors & neoplasms of gonads|78718627|2006
0-14|0.1|0.1|0.1|68|X(a) Intracranial & intraspinal germ cell tumors|58268801|2006
0-19|0.1|0.2|0.1|110|X(a) Intracranial & intraspinal germ cell tumors|78718627|2006
0-19|0.2|0.3|0.3|228|V Retinoblastoma|80201013|2005
0-14|0.7|0.9|0.8|484|VI Renal tumors|59582794|2005
0-14|0.1|0.2|0.2|90|XI(d) Malignant melanomas|55173748|2000
0-19|0.4|0.6|0.5|367|XI(d) Malignant melanomas|73649093|2000
0-14|0.5|0.6|0.5|1468|III(d) Other gliomas|274499921|2002-2006
0-19|0.5|0.5|0.5|1859|III(d) Other gliomas|368492797|2002-2006
0-19|0.5|0.5|0.5|2047|III(d) Other gliomas|408000943|2002-2006
0-14|0.0|0.1|0.0|23|III(f) Unspecified intracranial and intraspinal neoplasms|56123816|2002
0-19|0.0|0.1|0.0|28|III(f) Unspecified intracranial and intraspinal neoplasms|74939309|2002
0-19|~|~|~|~|IX(c) Kaposi sarcoma|79979457|2004
0-14|0.3|0.4|0.4|212|IX(d) Other specified soft tissue sarcomas|59678430|2004
0-19|0.5|0.6|0.5|406|IX(d) Other specified soft tissue sarcomas|79979457|2004
0-19|0.1|0.2|0.1|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78112034|2003
0-14|~|~|~|~|IX(c) Kaposi sarcoma|58431001|2003
0-19|~|~|~|~|IX(c) Kaposi sarcoma|78112034|2003
0-14|0.0|0.1|0.0|20|XI(c) Nasopharyngeal carcinomas|53943757|1999
0-19|0.0|0.1|0.1|39|XI(c) Nasopharyngeal carcinomas|71920580|1999
0-19|0.0|0.1|0.1|39|XI(c) Nasopharyngeal carcinomas|71920580|1999
0-19|0.1|0.2|0.1|110|X(a) Intracranial & intraspinal germ cell tumors|78718627|2006
0-19|0.6|0.7|0.6|526|VI Renal tumors|80201013|2005
0-19|0.6|0.7|0.7|526|VI Renal tumors|80201013|2005
0-19|0.4|0.6|0.5|367|XI(d) Malignant melanomas|73649093|2000
0-14|~|~|~|~|XI(e) Skin carcinomas|55173748|2000
0-19|~|~|~|~|XI(e) Skin carcinomas|73649093|2000
0-14|0.1|0.1|0.1|189|III(e) Other specified intracranial & intraspinal neoplasms|274499921|2002-2006
0-19|0.1|0.1|0.1|251|III(e) Other specified intracranial & intraspinal neoplasms|368492797|2002-2006
0-19|0.1|0.1|0.1|267|III(e) Other specified intracranial & intraspinal neoplasms|408000943|2002-2006
0-19|0.0|0.1|0.0|28|III(f) Unspecified intracranial and intraspinal neoplasms|74939309|2002
0-14|1.0|1.2|1.1|612|IV Neuroblastoma and other peripheral nervous cell tumors|56123816|2002
0-19|0.8|0.9|0.8|626|IV Neuroblastoma and other peripheral nervous cell tumors|74939309|2002
0-19|0.5|0.6|0.5|406|IX(d) Other specified soft tissue sarcomas|79979457|2004
0-19|~|~|~|~|IX(c) Kaposi sarcoma|78112034|2003
0-14|0.3|0.4|0.3|203|IX(d) Other specified soft tissue sarcomas|58431001|2003
0-19|0.4|0.5|0.5|360|IX(d) Other specified soft tissue sarcomas|78112034|2003
0-14|0.1|0.2|0.2|94|XI(d) Malignant melanomas|53943757|1999
0-19|0.4|0.5|0.5|334|XI(d) Malignant melanomas|71920580|1999
0-19|0.4|0.5|0.5|334|XI(d) Malignant melanomas|71920580|1999
0-14|0.1|0.2|0.1|82|X(b) Malignant extracranial & extragonadal germ cell tumors|58268801|2006
0-19|0.1|0.2|0.1|112|X(b) Malignant extracranial & extragonadal germ cell tumors|78718627|2006
0-19|0.1|0.2|0.1|112|X(b) Malignant extracranial & extragonadal germ cell tumors|78718627|2006
0-14|0.7|0.8|0.8|461|VI(a) Nephroblastoma and other nonepithelial renal tumors|59582794|2005
0-19|0.5|0.6|0.6|475|VI(a) Nephroblastoma and other nonepithelial renal tumors|80201013|2005
0-19|0.5|0.6|0.6|475|VI(a) Nephroblastoma and other nonepithelial renal tumors|80201013|2005
0-19|~|~|~|~|XI(e) Skin carcinomas|73649093|2000
0-14|0.1|0.2|0.1|79|XI(f) Other and unspecified carcinomas|55173748|2000
0-19|0.3|0.4|0.4|289|XI(f) Other and unspecified carcinomas|73649093|2000
0-19|0.1|0.2|0.1|611|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|408000943|2002-2006
0-14|0.1|0.1|0.1|61|IX(e) Unspecified soft tissue sarcomas|59678430|2004
0-19|0.1|0.1|0.1|98|IX(e) Unspecified soft tissue sarcomas|79979457|2004
0-19|0.1|0.1|0.1|98|IX(e) Unspecified soft tissue sarcomas|79979457|2004
0-19|0.4|0.5|0.5|360|IX(d) Other specified soft tissue sarcomas|78112034|2003
0-14|0.2|0.3|0.3|147|III(a) Ependymomas and choroid plexus tumor|58431001|2003
0-19|0.2|0.3|0.2|182|III(a) Ependymomas and choroid plexus tumor|78112034|2003
0-19|0.8|0.9|0.8|626|IV Neuroblastoma and other peripheral nervous cell tumors|74939309|2002
0-14|~|~|~|~|XI(e) Skin carcinomas|53943757|1999
0-19|~|~|~|~|XI(e) Skin carcinomas|71920580|1999
0-19|~|~|~|~|XI(e) Skin carcinomas|71920580|1999
0-14|0.2|0.3|0.2|127|X(c) Malignant gonadal germ cell tumors|58268801|2006
0-19|0.6|0.7|0.6|510|X(c) Malignant gonadal germ cell tumors|78718627|2006
0-19|0.6|0.7|0.6|510|X(c) Malignant gonadal germ cell tumors|78718627|2006
0-14|0.0|0.1|0.0|20|VI(b) Renal carcinomas|59582794|2005
0-19|0.0|0.1|0.1|48|VI(b) Renal carcinomas|80201013|2005
0-19|0.0|0.1|0.1|48|VI(b) Renal carcinomas|80201013|2005
0-19|0.3|0.4|0.4|289|XI(f) Other and unspecified carcinomas|73649093|2000
0-14|0.0|0.1|0.1|31|XII Other and unspecified malignant neoplasms|55173748|2000
0-19|0.0|0.1|0.1|45|XII Other and unspecified malignant neoplasms|73649093|2000
0-14|0.1|0.1|0.1|354|I(e) Unspecified and other specified leukemias|274499921|2002-2006
0-19|0.1|0.1|0.1|463|I(e) Unspecified and other specified leukemias|368492797|2002-2006
0-14|0.0|0.0|0.0|19|Not classified by ICCC|59678430|2004
0-19|0.0|0.1|0.0|31|Not classified by ICCC|79979457|2004
0-19|0.0|0.1|0.0|31|Not classified by ICCC|79979457|2004
0-19|0.2|0.3|0.2|182|III(a) Ependymomas and choroid plexus tumor|78112034|2003
0-14|~|~|~|~|X(d) Gonadal carcinomas|58268801|2006
0-19|0.0|0.1|0.0|39|X(d) Gonadal carcinomas|78718627|2006
0-19|0.0|0.1|0.0|39|X(d) Gonadal carcinomas|78718627|2006
0-14|0.1|0.2|0.2|81|XI(f) Other and unspecified carcinomas|53943757|1999
0-19|0.3|0.4|0.4|272|XI(f) Other and unspecified carcinomas|71920580|1999
0-14|1.0|1.2|1.1|606|IV(a) Neuroblastoma and ganglioneuroblastoma|56123816|2002
0-19|0.7|0.9|0.8|611|IV(a) Neuroblastoma and ganglioneuroblastoma|74939309|2002
0-19|0.8|0.9|0.8|611|IV(a) Neuroblastoma and ganglioneuroblastoma|74939309|2002
0-14|1.0|1.2|1.1|693|IV Neuroblastoma and other peripheral nervous cell tumors|59582794|2005
0-19|0.8|0.9|0.9|708|IV Neuroblastoma and other peripheral nervous cell tumors|80201013|2005
0-19|0.0|0.1|0.1|45|XII Other and unspecified malignant neoplasms|73649093|2000
0-19|0.1|0.1|0.1|501|I(e) Unspecified and other specified leukemias|408000943|2002-2006
0-14|1.6|1.7|1.6|4439|II Lymphomas and reticuloendothelial neoplasms|274499921|2002-2006
0-19|2.4|2.5|2.5|9154|II Lymphomas and reticuloendothelial neoplasms|368492797|2002-2006
0-14|0.4|0.5|0.4|254|V Retinoblastoma|59678430|2004
0-19|0.3|0.3|0.3|254|V Retinoblastoma|79979457|2004
0-19|0.3|0.4|0.3|254|V Retinoblastoma|79979457|2004
0-14|1.5|1.7|1.6|923|III(b) Astrocytomas|58431001|2003
0-19|1.4|1.6|1.5|1153|III(b) Astrocytomas|78112034|2003
0-19|1.4|1.6|1.5|1153|III(b) Astrocytomas|78112034|2003
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|58268801|2006
0-19|0.0|0.0|0.0|22|X(e) Other and unspecified malignant gonadal tumors|78718627|2006
0-19|0.0|0.1|0.0|32|VIII(d) Other specified malignant bone tumors|71920580|1999
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|53943757|1999
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|71920580|1999
0-14|~|~|~|~|XII(a) Other specified malignant tumors|55173748|2000
0-19|~|~|~|~|XII(a) Other specified malignant tumors|73649093|2000
0-19|~|~|~|~|XII(a) Other specified malignant tumors|73649093|2000
0-19|0.8|1.0|0.9|708|IV Neuroblastoma and other peripheral nervous cell tumors|80201013|2005
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|56123816|2002
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|74939309|2002
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|74939309|2002
0-19|2.4|2.5|2.5|10058|II Lymphomas and reticuloendothelial neoplasms|408000943|2002-2006
0-14|0.5|0.6|0.5|311|III(d) Other gliomas|59678430|2004
0-19|0.4|0.5|0.5|390|III(d) Other gliomas|79979457|2004
0-19|0.4|0.5|0.5|390|III(d) Other gliomas|79979457|2004
0-14|0.6|0.8|0.7|416|III(c) Intracranial and intraspinal embryonal tumors|58431001|2003
0-19|0.6|0.7|0.6|471|III(c) Intracranial and intraspinal embryonal tumors|78112034|2003
0-19|0.5|0.7|0.6|471|III(c) Intracranial and intraspinal embryonal tumors|78112034|2003
0-19|0.0|0.0|0.0|22|X(e) Other and unspecified malignant gonadal tumors|78718627|2006
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|71920580|1999
0-14|0.0|0.1|0.0|19|XII(b) Other unspecified malignant tumors|55173748|2000
0-19|0.0|0.1|0.0|31|XII(b) Other unspecified malignant tumors|73649093|2000
0-14|0.1|0.2|0.1|80|X(a) Intracranial & intraspinal germ cell tumors|55173748|2000
0-19|0.1|0.2|0.2|122|X(a) Intracranial & intraspinal germ cell tumors|73649093|2000
0-14|1.0|1.2|1.1|685|IV(a) Neuroblastoma and ganglioneuroblastoma|59582794|2005
0-19|0.8|0.9|0.8|695|IV(a) Neuroblastoma and ganglioneuroblastoma|80201013|2005
0-19|0.8|0.9|0.9|695|IV(a) Neuroblastoma and ganglioneuroblastoma|80201013|2005
0-14|0.5|0.6|0.6|1564|II(a) Hodgkin lymphomas|274499921|2002-2006
0-19|1.2|1.3|1.2|4597|II(a) Hodgkin lymphomas|368492797|2002-2006
0-19|1.2|1.3|1.2|5027|II(a) Hodgkin lymphomas|408000943|2002-2006
0-14|0.1|0.1|0.1|47|III(e) Other specified intracranial & intraspinal neoplasms|59678430|2004
0-19|0.1|0.1|0.1|57|III(e) Other specified intracranial & intraspinal neoplasms|79979457|2004
0-14|0.5|0.6|0.6|330|III(d) Other gliomas|58431001|2003
0-19|0.5|0.6|0.5|404|III(d) Other gliomas|78112034|2003
0-19|0.5|0.6|0.5|404|III(d) Other gliomas|78112034|2003
0-14|1.0|1.2|1.1|615|IX Soft tissue and other extraosseous sarcomas|56123816|2002
0-19|1.1|1.3|1.2|885|IX Soft tissue and other extraosseous sarcomas|74939309|2002
0-14|0.0|0.1|0.0|23|VII(b) Hepatic carcinomas|58268801|2006
0-19|0.0|0.1|0.1|51|VII(b) Hepatic carcinomas|78718627|2006
0-19|0.0|0.1|0.1|51|VII(b) Hepatic carcinomas|78718627|2006
0-14|0.4|0.6|0.5|265|X Germ cell, trophoblastic tumors & neoplasms of gonads|53943757|1999
0-19|0.9|1.1|1.0|729|X Germ cell, trophoblastic tumors & neoplasms of gonads|71920580|1999
0-19|0.9|1.1|1.0|729|X Germ cell, trophoblastic tumors & neoplasms of gonads|71920580|1999
0-19|0.1|0.2|0.2|122|X(a) Intracranial & intraspinal germ cell tumors|73649093|2000
0-14|0.1|0.1|0.1|60|X(b) Malignant extracranial & extragonadal germ cell tumors|55173748|2000
0-19|0.1|0.2|0.1|101|X(b) Malignant extracranial & extragonadal germ cell tumors|73649093|2000
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|59582794|2005
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|80201013|2005
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|80201013|2005
0-19|0.1|0.1|0.1|57|III(e) Other specified intracranial & intraspinal neoplasms|79979457|2004
0-14|0.0|0.1|0.1|35|III(f) Unspecified intracranial and intraspinal neoplasms|59678430|2004
0-19|0.0|0.1|0.1|42|III(f) Unspecified intracranial and intraspinal neoplasms|79979457|2004
0-14|0.1|0.1|0.1|46|III(e) Other specified intracranial & intraspinal neoplasms|58431001|2003
0-19|0.1|0.1|0.1|56|III(e) Other specified intracranial & intraspinal neoplasms|78112034|2003
0-14|0.6|0.7|0.6|1784|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|274499921|2002-2006
0-19|0.8|0.9|0.9|3158|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|368492797|2002-2006
0-19|0.8|0.9|0.9|3501|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|408000943|2002-2006
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|58268801|2006
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78718627|2006
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|78718627|2006
0-19|0.1|0.2|0.1|101|X(b) Malignant extracranial & extragonadal germ cell tumors|73649093|2000
0-14|0.1|0.2|0.1|70|X(a) Intracranial & intraspinal germ cell tumors|53943757|1999
0-19|0.1|0.2|0.1|101|X(a) Intracranial & intraspinal germ cell tumors|71920580|1999
0-14|0.9|1.1|1.0|615|IX Soft tissue and other extraosseous sarcomas|59582794|2005
0-19|1.1|1.3|1.2|970|IX Soft tissue and other extraosseous sarcomas|80201013|2005
0-19|0.0|0.1|0.1|42|III(f) Unspecified intracranial and intraspinal neoplasms|79979457|2004
0-19|0.1|0.1|0.1|56|III(e) Other specified intracranial & intraspinal neoplasms|78112034|2003
0-14|0.0|0.1|0.0|21|III(f) Unspecified intracranial and intraspinal neoplasms|58431001|2003
0-19|0.0|0.1|0.0|30|III(f) Unspecified intracranial and intraspinal neoplasms|78112034|2003
0-14|0.2|0.3|0.3|702|II(c) Burkitt lymphoma|274499921|2002-2006
0-19|0.2|0.3|0.3|928|II(c) Burkitt lymphoma|368492797|2002-2006
0-19|0.8|0.9|0.8|617|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74939309|2002
0-14|0.2|0.3|0.3|151|II(c) Burkitt lymphoma|56123816|2002
0-19|0.2|0.3|0.3|201|II(c) Burkitt lymphoma|74939309|2002
0-14|0.6|0.8|0.7|394|VIII Malignant bone tumors|58268801|2006
0-19|0.8|1.0|0.9|718|VIII Malignant bone tumors|78718627|2006
0-19|0.8|1.0|0.9|718|VIII Malignant bone tumors|78718627|2006
0-14|0.2|0.3|0.2|122|X(c) Malignant gonadal germ cell tumors|55173748|2000
0-19|0.6|0.8|0.7|509|X(c) Malignant gonadal germ cell tumors|73649093|2000
0-19|0.6|0.8|0.7|509|X(c) Malignant gonadal germ cell tumors|73649093|2000
0-19|0.1|0.2|0.1|101|X(a) Intracranial & intraspinal germ cell tumors|71920580|1999
0-14|0.1|0.2|0.1|73|X(b) Malignant extracranial & extragonadal germ cell tumors|53943757|1999
0-19|0.1|0.2|0.1|99|X(b) Malignant extracranial & extragonadal germ cell tumors|71920580|1999
0-19|1.1|1.3|1.2|970|IX Soft tissue and other extraosseous sarcomas|80201013|2005
0-14|0.5|0.6|0.5|309|IX(a) Rhabdomyosarcomas|59582794|2005
0-19|0.4|0.5|0.5|383|IX(a) Rhabdomyosarcomas|80201013|2005
0-14|1.0|1.2|1.1|661|IV Neuroblastoma and other peripheral nervous cell tumors|59678430|2004
0-19|0.8|0.9|0.8|677|IV Neuroblastoma and other peripheral nervous cell tumors|79979457|2004
0-19|0.8|0.9|0.8|677|IV Neuroblastoma and other peripheral nervous cell tumors|79979457|2004
0-19|0.0|0.1|0.0|30|III(f) Unspecified intracranial and intraspinal neoplasms|78112034|2003
0-19|0.2|0.3|0.2|1013|II(c) Burkitt lymphoma|408000943|2002-2006
0-14|0.1|0.1|0.1|332|II(d) Miscellaneous lymphoreticular neoplasms|274499921|2002-2006
0-19|0.1|0.1|0.1|355|II(d) Miscellaneous lymphoreticular neoplasms|368492797|2002-2006
0-19|0.2|0.3|0.3|201|II(c) Burkitt lymphoma|74939309|2002
0-14|0.1|0.1|0.1|61|II(d) Miscellaneous lymphoreticular neoplasms|56123816|2002
0-19|0.1|0.1|0.1|62|II(d) Miscellaneous lymphoreticular neoplasms|74939309|2002
0-14|0.3|0.4|0.4|225|VIII(a) Osteosarcomas|58268801|2006
0-19|0.5|0.6|0.5|416|VIII(a) Osteosarcomas|78718627|2006
0-14|~|~|~|~|X(d) Gonadal carcinomas|55173748|2000
0-19|0.0|0.1|0.0|33|X(d) Gonadal carcinomas|73649093|2000
0-19|0.0|0.1|0.0|33|X(d) Gonadal carcinomas|73649093|2000
0-19|0.1|0.2|0.1|99|X(b) Malignant extracranial & extragonadal germ cell tumors|71920580|1999
0-19|0.4|0.5|0.5|383|IX(a) Rhabdomyosarcomas|80201013|2005
0-14|0.1|0.1|0.1|63|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59582794|2005
0-19|0.1|0.2|0.1|107|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80201013|2005
0-14|1.0|1.1|1.1|647|IV(a) Neuroblastoma and ganglioneuroblastoma|59678430|2004
0-19|0.7|0.9|0.8|655|IV(a) Neuroblastoma and ganglioneuroblastoma|79979457|2004
0-14|1.0|1.1|1.0|612|IV Neuroblastoma and other peripheral nervous cell tumors|58431001|2003
0-19|0.7|0.9|0.8|627|IV Neuroblastoma and other peripheral nervous cell tumors|78112034|2003
0-19|0.7|0.9|0.8|627|IV Neuroblastoma and other peripheral nervous cell tumors|78112034|2003
0-19|0.1|0.1|0.1|395|II(d) Miscellaneous lymphoreticular neoplasms|408000943|2002-2006
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|55173748|2000
0-19|0.0|0.0|0.0|16|X(e) Other and unspecified malignant gonadal tumors|73649093|2000
0-19|0.5|0.6|0.5|416|VIII(a) Osteosarcomas|78718627|2006
0-14|~|~|~|~|VIII(b) Chondrosarcomas|58268801|2006
0-19|0.0|0.0|0.0|18|VIII(b) Chondrosarcomas|78718627|2006
0-14|0.2|0.2|0.2|111|X(c) Malignant gonadal germ cell tumors|53943757|1999
0-19|0.6|0.7|0.7|485|X(c) Malignant gonadal germ cell tumors|71920580|1999
0-19|0.6|0.7|0.7|485|X(c) Malignant gonadal germ cell tumors|71920580|1999
0-19|0.1|0.2|0.1|107|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|80201013|2005
0-19|0.8|0.9|0.8|655|IV(a) Neuroblastoma and ganglioneuroblastoma|79979457|2004
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|59678430|2004
0-19|0.0|0.0|0.0|22|IV(b) Other peripheral nervous cell tumors|79979457|2004
0-19|0.1|0.1|0.1|62|II(d) Miscellaneous lymphoreticular neoplasms|74939309|2002
0-14|1.5|1.7|1.6|928|II Lymphomas and reticuloendothelial neoplasms|58431001|2003
0-19|2.3|2.5|2.4|1881|II Lymphomas and reticuloendothelial neoplasms|78112034|2003
0-19|0.0|0.1|0.0|35|XII(a) Other specified malignant tumors|74939309|2002
0-14|~|~|~|~|XII(b) Other unspecified malignant tumors|56123816|2002
0-19|0.0|0.0|0.0|23|XII(b) Other unspecified malignant tumors|74939309|2002
0-19|0.0|0.0|0.0|16|X(e) Other and unspecified malignant gonadal tumors|73649093|2000
0-14|0.5|0.6|0.6|306|XI Other malignant epithelial neoplasms and malignant melanomas|55173748|2000
0-19|1.4|1.6|1.5|1128|XI Other malignant epithelial neoplasms and malignant melanomas|73649093|2000
0-19|0.0|0.0|0.0|18|VIII(b) Chondrosarcomas|78718627|2006
0-14|0.2|0.3|0.2|132|VIII(c) Ewing tumor and related sarcomas of bone|58268801|2006
0-19|0.3|0.3|0.3|230|VIII(c) Ewing tumor and related sarcomas of bone|78718627|2006
0-14|~|~|~|~|X(d) Gonadal carcinomas|53943757|1999
0-19|0.0|0.1|0.0|31|X(d) Gonadal carcinomas|71920580|1999
0-19|0.0|0.1|0.0|31|X(d) Gonadal carcinomas|71920580|1999
0-14|~|~|~|~|IX(c) Kaposi sarcoma|59582794|2005
0-19|~|~|~|~|IX(c) Kaposi sarcoma|80201013|2005
0-19|0.0|0.0|0.0|22|IV(b) Other peripheral nervous cell tumors|79979457|2004
0-19|2.3|2.5|2.4|1881|II Lymphomas and reticuloendothelial neoplasms|78112034|2003
0-14|0.5|0.6|0.6|340|II(a) Hodgkin lymphomas|58431001|2003
0-19|1.2|1.3|1.2|970|II(a) Hodgkin lymphomas|78112034|2003
0-19|1.4|1.6|1.5|1128|XI Other malignant epithelial neoplasms and malignant melanomas|73649093|2000
0-19|0.0|0.0|0.0|23|XII(b) Other unspecified malignant tumors|74939309|2002
0-19|0.3|0.3|0.3|230|VIII(c) Ewing tumor and related sarcomas of bone|78718627|2006
0-14|~|~|~|~|II(e) Unspecified lymphomas|56123816|2002
0-19|0.0|0.0|0.0|24|II(e) Unspecified lymphomas|74939309|2002
0-19|0.0|0.0|0.0|24|II(e) Unspecified lymphomas|74939309|2002
0-14|3.0|3.3|3.1|1863|III CNS and misc intracranial and intraspinal neoplasms|59582794|2005
0-19|2.8|3.0|2.9|2304|III CNS and misc intracranial and intraspinal neoplasms|80201013|2005
0-19|2.8|3.0|2.9|2304|III CNS and misc intracranial and intraspinal neoplasms|80201013|2005
0-14|0.1|0.2|0.2|91|VII(a) Hepatoblastoma|53943757|1999
0-19|0.1|0.2|0.1|92|VII(a) Hepatoblastoma|71920580|1999
0-14|0.3|0.4|0.3|189|III(a) Ependymomas and choroid plexus tumor|59582794|2005
0-19|0.2|0.3|0.3|227|III(a) Ependymomas and choroid plexus tumor|80201013|2005
0-19|0.1|0.2|0.1|92|VII(a) Hepatoblastoma|71920580|1999
0-14|0.0|0.1|0.0|21|VII(b) Hepatic carcinomas|53943757|1999
0-19|0.1|0.1|0.1|51|VII(b) Hepatic carcinomas|71920580|1999
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|55173748|2000
0-19|0.0|0.0|0.0|22|XI(a) Adrenocortical carcinomas|73649093|2000
0-19|0.0|0.0|0.0|22|XI(a) Adrenocortical carcinomas|73649093|2000
0-19|0.2|0.3|0.3|227|III(a) Ependymomas and choroid plexus tumor|80201013|2005
0-14|1.5|1.7|1.6|927|III(b) Astrocytomas|59582794|2005
0-19|1.4|1.5|1.5|1164|III(b) Astrocytomas|80201013|2005
0-14|0.6|0.7|0.7|366|VIII Malignant bone tumors|55173748|2000
0-19|0.8|0.9|0.8|622|VIII Malignant bone tumors|73649093|2000
0-19|0.8|0.9|0.8|622|VIII Malignant bone tumors|73649093|2000
0-19|1.4|1.5|1.5|1164|III(b) Astrocytomas|80201013|2005
0-14|0.6|0.7|0.7|403|III(c) Intracranial and intraspinal embryonal tumors|59582794|2005
0-19|0.5|0.6|0.6|458|III(c) Intracranial and intraspinal embryonal tumors|80201013|2005
0-19|0.5|0.6|0.6|458|III(c) Intracranial and intraspinal embryonal tumors|80201013|2005
0-14|0.4|0.5|0.5|282|III(d) Other gliomas|59582794|2005
0-19|0.4|0.5|0.5|366|III(d) Other gliomas|80201013|2005
0-19|0.4|0.5|0.5|366|III(d) Other gliomas|80201013|2005
0-14|3.2|3.5|3.4|1881|III CNS and misc intracranial and intraspinal neoplasms|56123816|2002
0-19|2.9|3.2|3.1|2284|III CNS and misc intracranial and intraspinal neoplasms|74939309|2002
0-19|2.9|3.2|3.0|2284|III CNS and misc intracranial and intraspinal neoplasms|74939309|2002
0-14|0.0|0.1|0.1|37|III(e) Other specified intracranial & intraspinal neoplasms|59582794|2005
0-19|0.0|0.1|0.1|52|III(e) Other specified intracranial & intraspinal neoplasms|80201013|2005
0-19|0.0|0.1|0.1|52|III(e) Other specified intracranial & intraspinal neoplasms|80201013|2005
0-14|0.3|0.4|0.4|202|III(a) Ependymomas and choroid plexus tumor|56123816|2002
0-19|0.3|0.3|0.3|222|III(a) Ependymomas and choroid plexus tumor|74939309|2002
0-14|0.0|0.1|0.0|25|III(f) Unspecified intracranial and intraspinal neoplasms|59582794|2005
0-19|0.0|0.1|0.0|37|III(f) Unspecified intracranial and intraspinal neoplasms|80201013|2005
0-14|0.3|0.4|0.4|202|VIII(a) Osteosarcomas|55173748|2000
0-19|0.4|0.5|0.5|352|VIII(a) Osteosarcomas|73649093|2000
0-19|0.4|0.5|0.5|352|VIII(a) Osteosarcomas|73649093|2000
0-19|0.3|0.3|0.3|222|III(a) Ependymomas and choroid plexus tumor|74939309|2002
0-14|1.5|1.7|1.6|875|III(b) Astrocytomas|56123816|2002
0-19|1.4|1.6|1.5|1097|III(b) Astrocytomas|74939309|2002
0-19|0.0|0.1|0.0|37|III(f) Unspecified intracranial and intraspinal neoplasms|80201013|2005
0-19|0.1|0.2|0.1|118|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|80201013|2005
0-14|0.1|0.2|0.1|79|I(e) Unspecified and other specified leukemias|59582794|2005
0-19|0.1|0.2|0.1|100|I(e) Unspecified and other specified leukemias|80201013|2005
0-14|~|~|~|~|VIII(b) Chondrosarcomas|55173748|2000
0-19|~|~|~|~|VIII(b) Chondrosarcomas|73649093|2000
0-19|1.2|1.3|1.2|970|II(a) Hodgkin lymphomas|78112034|2003
0-14|0.6|0.7|0.6|371|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|58431001|2003
0-19|0.7|0.9|0.8|634|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78112034|2003
0-19|0.1|0.1|0.1|51|VII(b) Hepatic carcinomas|71920580|1999
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|53943757|1999
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|71920580|1999
0-19|0.1|0.2|0.1|100|I(e) Unspecified and other specified leukemias|80201013|2005
0-14|1.5|1.8|1.6|980|II Lymphomas and reticuloendothelial neoplasms|59582794|2005
0-19|2.5|2.7|2.6|2069|II Lymphomas and reticuloendothelial neoplasms|80201013|2005
0-19|2.5|2.7|2.6|2069|II Lymphomas and reticuloendothelial neoplasms|80201013|2005
0-19|~|~|~|~|VIII(b) Chondrosarcomas|73649093|2000
0-14|0.2|0.3|0.3|145|VIII(c) Ewing tumor and related sarcomas of bone|55173748|2000
0-19|0.3|0.3|0.3|223|VIII(c) Ewing tumor and related sarcomas of bone|73649093|2000
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|71920580|1999
0-14|1.0|1.1|1.0|628|IX Soft tissue and other extraosseous sarcomas|59678430|2004
0-19|1.1|1.3|1.2|961|IX Soft tissue and other extraosseous sarcomas|79979457|2004
0-19|0.8|0.9|0.9|683|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|79979457|2004
0-19|1.4|1.6|1.5|1097|III(b) Astrocytomas|74939309|2002
0-14|0.7|0.8|0.7|416|III(c) Intracranial and intraspinal embryonal tumors|56123816|2002
0-19|0.6|0.7|0.6|477|III(c) Intracranial and intraspinal embryonal tumors|74939309|2002
0-19|0.7|0.9|0.8|634|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|78112034|2003
0-14|0.5|0.7|0.6|348|II(a) Hodgkin lymphomas|59582794|2005
0-19|1.2|1.3|1.3|1027|II(a) Hodgkin lymphomas|80201013|2005
0-19|1.2|1.4|1.3|1027|II(a) Hodgkin lymphomas|80201013|2005
0-19|0.3|0.3|0.3|223|VIII(c) Ewing tumor and related sarcomas of bone|73649093|2000
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|55173748|2000
0-19|0.0|0.0|0.0|18|VIII(d) Other specified malignant bone tumors|73649093|2000
0-14|0.2|0.3|0.2|144|II(c) Burkitt lymphoma|59678430|2004
0-19|0.2|0.3|0.2|187|II(c) Burkitt lymphoma|79979457|2004
0-19|0.2|0.3|0.2|187|II(c) Burkitt lymphoma|79979457|2004
0-19|3.0|3.3|3.1|2350|I(a) Lymphoid leukemias|74939309|2002
0-14|0.6|0.8|0.7|385|VIII Malignant bone tumors|53943757|1999
0-19|0.8|1.0|0.9|631|VIII Malignant bone tumors|71920580|1999
0-19|0.8|0.9|0.9|631|VIII Malignant bone tumors|71920580|1999
0-14|0.1|0.2|0.1|76|II(d) Miscellaneous lymphoreticular neoplasms|59678430|2004
0-19|0.1|0.1|0.1|81|II(d) Miscellaneous lymphoreticular neoplasms|79979457|2004
0-19|0.1|0.1|0.1|81|II(d) Miscellaneous lymphoreticular neoplasms|79979457|2004
0-14|0.7|0.9|0.8|443|I(b) Acute myeloid leukemias|56123816|2002
0-19|0.8|0.9|0.8|616|I(b) Acute myeloid leukemias|74939309|2002
0-19|0.8|0.9|0.8|616|I(b) Acute myeloid leukemias|74939309|2002
0-14|0.6|0.7|0.6|381|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59582794|2005
0-19|0.8|1.0|0.9|723|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80201013|2005
0-14|0.2|0.3|0.3|152|II(c) Burkitt lymphoma|58431001|2003
0-19|0.2|0.3|0.3|198|II(c) Burkitt lymphoma|78112034|2003
0-19|0.2|0.3|0.3|198|II(c) Burkitt lymphoma|78112034|2003
0-14|0.4|0.5|0.4|228|VIII(a) Osteosarcomas|53943757|1999
0-19|0.5|0.6|0.5|367|VIII(a) Osteosarcomas|71920580|1999
0-19|0.5|0.6|0.5|367|VIII(a) Osteosarcomas|71920580|1999
0-14|0.1|0.2|0.2|87|I(c) Chronic myeloproliferative diseases|56123816|2002
0-19|0.2|0.2|0.2|151|I(c) Chronic myeloproliferative diseases|74939309|2002
0-19|0.2|0.2|0.2|151|I(c) Chronic myeloproliferative diseases|74939309|2002
0-19|0.8|1.0|0.9|723|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|80201013|2005
0-14|0.2|0.3|0.3|153|II(c) Burkitt lymphoma|59582794|2005
0-19|0.2|0.3|0.2|199|II(c) Burkitt lymphoma|80201013|2005
0-14|~|~|~|~|VIII(b) Chondrosarcomas|53943757|1999
0-19|0.0|0.1|0.0|25|VIII(b) Chondrosarcomas|71920580|1999
0-19|0.0|0.1|0.0|25|VIII(b) Chondrosarcomas|71920580|1999
0-19|0.2|0.3|0.2|199|II(c) Burkitt lymphoma|80201013|2005
0-14|0.1|0.2|0.1|85|II(d) Miscellaneous lymphoreticular neoplasms|59582794|2005
0-19|0.1|0.1|0.1|93|II(d) Miscellaneous lymphoreticular neoplasms|80201013|2005
0-14|0.1|0.2|0.2|90|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|56123816|2002
0-19|0.1|0.2|0.2|113|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74939309|2002
0-14|0.2|0.3|0.2|128|VIII(c) Ewing tumor and related sarcomas of bone|53943757|1999
0-19|0.2|0.3|0.3|197|VIII(c) Ewing tumor and related sarcomas of bone|71920580|1999
0-19|0.0|0.0|0.0|18|VIII(d) Other specified malignant bone tumors|73649093|2000
0-19|0.1|0.2|0.2|113|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74939309|2002
0-14|0.1|0.2|0.1|75|I(e) Unspecified and other specified leukemias|56123816|2002
0-19|0.1|0.2|0.1|93|I(e) Unspecified and other specified leukemias|74939309|2002
0-19|16.8|17.0|16.9|62628|All ICCC Groups Combined|368492797|2002-2006
0-14|15.2|15.5|15.3|42277|All ICCC Groups Combined|274499921|2002-2006
0-19|16.8|17.1|16.9|69150|All ICCC Groups Combined|408000943|2002-2006
0-14|0.0|0.0|0.0|17|VIII(d) Other specified malignant bone tumors|58268801|2006
0-19|0.0|0.1|0.0|39|VIII(d) Other specified malignant bone tumors|78718627|2006
0-19|0.0|0.1|0.0|39|VIII(d) Other specified malignant bone tumors|78718627|2006
0-14|0.0|0.0|0.0|17|II(e) Unspecified lymphomas|59678430|2004
0-19|0.0|0.1|0.0|32|II(e) Unspecified lymphomas|79979457|2004
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|55173748|2000
0-19|0.0|0.0|0.0|16|VIII(e) Unspecified malignant bone tumors|73649093|2000
0-19|0.0|0.0|0.0|16|VIII(e) Unspecified malignant bone tumors|73649093|2000
0-19|0.2|0.3|0.3|197|VIII(c) Ewing tumor and related sarcomas of bone|71920580|1999
0-14|0.0|0.0|0.0|16|VIII(d) Other specified malignant bone tumors|53943757|1999
0-19|0.0|0.1|0.0|32|VIII(d) Other specified malignant bone tumors|71920580|1999
0-19|0.1|0.2|0.1|90|IX(e) Unspecified soft tissue sarcomas|71920580|1999
0-14|0.0|0.0|0.0|16|Not classified by ICCC|53943757|1999
0-19|0.0|0.0|0.0|23|Not classified by ICCC|71920580|1999
0-19|0.1|0.2|0.1|93|I(e) Unspecified and other specified leukemias|74939309|2002
0-14|0.1|0.1|0.1|58|II(d) Miscellaneous lymphoreticular neoplasms|58431001|2003
0-19|0.1|0.1|0.1|62|II(d) Miscellaneous lymphoreticular neoplasms|78112034|2003
0-19|0.1|0.1|0.1|62|II(d) Miscellaneous lymphoreticular neoplasms|78112034|2003
0-14|4.8|4.9|4.9|13396|I Leukemias, myeloproliferative & myelodysplastic diseases|274499921|2002-2006
0-19|4.3|4.5|4.4|16309|I Leukemias, myeloproliferative & myelodysplastic diseases|368492797|2002-2006
0-19|4.4|4.5|4.5|18173|I Leukemias, myeloproliferative & myelodysplastic diseases|408000943|2002-2006
0-14|0.4|0.6|0.5|273|X Germ cell, trophoblastic tumors & neoplasms of gonads|55173748|2000
0-19|1.0|1.1|1.1|781|X Germ cell, trophoblastic tumors & neoplasms of gonads|73649093|2000
0-19|1.0|1.1|1.1|781|X Germ cell, trophoblastic tumors & neoplasms of gonads|73649093|2000
0-19|0.0|0.1|0.0|32|II(e) Unspecified lymphomas|79979457|2004
0-14|3.2|3.5|3.4|2000|III CNS and misc intracranial and intraspinal neoplasms|59678430|2004
0-19|3.0|3.2|3.1|2464|III CNS and misc intracranial and intraspinal neoplasms|79979457|2004
0-19|0.0|0.0|0.0|23|Not classified by ICCC|71920580|1999
0-14|0.4|0.5|0.4|229|V Retinoblastoma|53943757|1999
0-19|0.3|0.4|0.3|230|V Retinoblastoma|71920580|1999
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|58268801|2006
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|78718627|2006
0-19|0.0|0.0|0.0|25|Not classified by ICCC|78718627|2006
0-14|~|~|~|~|II(e) Unspecified lymphomas|58431001|2003
0-19|0.0|0.0|0.0|17|II(e) Unspecified lymphomas|78112034|2003
0-19|0.0|0.0|0.0|17|II(e) Unspecified lymphomas|78112034|2003
0-14|3.6|3.8|3.7|10121|I(a) Lymphoid leukemias|274499921|2002-2006
0-19|3.1|3.2|3.2|11629|I(a) Lymphoid leukemias|368492797|2002-2006
0-14|1.5|1.7|1.6|876|II Lymphomas and reticuloendothelial neoplasms|56123816|2002
0-19|2.3|2.5|2.4|1814|II Lymphomas and reticuloendothelial neoplasms|74939309|2002
0-19|2.3|2.5|2.4|1814|II Lymphomas and reticuloendothelial neoplasms|74939309|2002
0-14|3.1|3.4|3.2|1883|III CNS and misc intracranial and intraspinal neoplasms|58431001|2003
0-19|2.8|3.1|2.9|2296|III CNS and misc intracranial and intraspinal neoplasms|78112034|2003
0-19|3.0|3.2|3.1|2464|III CNS and misc intracranial and intraspinal neoplasms|79979457|2004
0-14|0.3|0.3|0.3|178|III(a) Ependymomas and choroid plexus tumor|59678430|2004
0-19|0.3|0.4|0.3|230|V Retinoblastoma|71920580|1999
0-14|0.7|0.9|0.8|434|VI Renal tumors|53943757|1999
0-19|0.6|0.7|0.6|460|VI Renal tumors|71920580|1999
0-14|0.3|0.4|0.4|232|V Retinoblastoma|58268801|2006
0-19|0.2|0.3|0.3|233|V Retinoblastoma|78718627|2006
0-19|0.3|0.3|0.3|233|V Retinoblastoma|78718627|2006
0-14|0.7|0.9|0.8|445|VI(a) Nephroblastoma and other nonepithelial renal tumors|55173748|2000
0-19|0.6|0.7|0.6|450|VI(a) Nephroblastoma and other nonepithelial renal tumors|73649093|2000
0-19|0.6|0.7|0.6|450|VI(a) Nephroblastoma and other nonepithelial renal tumors|73649093|2000
0-19|3.1|3.2|3.2|13000|I(a) Lymphoid leukemias|408000943|2002-2006
0-14|0.7|0.8|0.8|2092|I(b) Acute myeloid leukemias|274499921|2002-2006
0-19|0.8|0.8|0.8|2934|I(b) Acute myeloid leukemias|368492797|2002-2006
0-19|0.2|0.3|0.3|219|III(a) Ependymomas and choroid plexus tumor|79979457|2004
0-19|0.2|0.3|0.3|219|III(a) Ependymomas and choroid plexus tumor|79979457|2004
0-19|0.6|0.7|0.6|460|VI Renal tumors|71920580|1999
0-14|0.7|0.8|0.8|410|VI(a) Nephroblastoma and other nonepithelial renal tumors|53943757|1999
0-19|2.8|3.1|2.9|2296|III CNS and misc intracranial and intraspinal neoplasms|78112034|2003
0-14|0.7|0.9|0.8|481|VI Renal tumors|58268801|2006
0-19|0.6|0.7|0.7|527|VI Renal tumors|78718627|2006
0-19|0.6|0.7|0.7|527|VI Renal tumors|78718627|2006
0-14|0.0|0.1|0.0|21|VI(b) Renal carcinomas|55173748|2000
0-19|0.0|0.1|0.0|35|VI(b) Renal carcinomas|73649093|2000
0-19|0.0|0.1|0.0|35|VI(b) Renal carcinomas|73649093|2000
0-19|0.8|0.8|0.8|3266|I(b) Acute myeloid leukemias|408000943|2002-2006
0-14|0.1|0.2|0.1|391|I(c) Chronic myeloproliferative diseases|274499921|2002-2006
0-19|0.2|0.2|0.2|734|I(c) Chronic myeloproliferative diseases|368492797|2002-2006
0-14|1.5|1.7|1.6|974|III(b) Astrocytomas|59678430|2004
0-19|1.5|1.6|1.6|1240|III(b) Astrocytomas|79979457|2004
0-19|1.5|1.6|1.6|1240|III(b) Astrocytomas|79979457|2004
0-14|14.7|15.3|15.0|8801|All ICCC Groups Combined|58431001|2003
0-19|16.3|16.8|16.5|12960|All ICCC Groups Combined|78112034|2003
0-19|16.3|16.9|16.6|12960|All ICCC Groups Combined|78112034|2003
0-19|0.5|0.6|0.6|419|VI(a) Nephroblastoma and other nonepithelial renal tumors|71920580|1999
0-19|0.5|0.6|0.6|419|VI(a) Nephroblastoma and other nonepithelial renal tumors|71920580|1999
0-14|0.7|0.8|0.8|461|VI(a) Nephroblastoma and other nonepithelial renal tumors|58268801|2006
0-19|0.5|0.6|0.6|468|VI(a) Nephroblastoma and other nonepithelial renal tumors|78718627|2006
0-19|0.5|0.7|0.6|468|VI(a) Nephroblastoma and other nonepithelial renal tumors|78718627|2006
0-14|0.0|0.1|0.0|21|VI(b) Renal carcinomas|53943757|1999
0-19|0.0|0.1|0.1|37|VI(b) Renal carcinomas|71920580|1999
0-19|0.0|0.1|0.1|37|VI(b) Renal carcinomas|71920580|1999
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|55173748|2000
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|73649093|2000
0-19|0.2|0.2|0.2|795|I(c) Chronic myeloproliferative diseases|408000943|2002-2006
0-14|0.7|0.8|0.8|455|III(c) Intracranial and intraspinal embryonal tumors|59678430|2004
0-19|0.6|0.7|0.6|516|III(c) Intracranial and intraspinal embryonal tumors|79979457|2004
0-19|0.6|0.7|0.6|516|III(c) Intracranial and intraspinal embryonal tumors|79979457|2004
0-14|4.5|4.9|4.7|2747|I Leukemias, myeloproliferative & myelodysplastic diseases|58431001|2003
0-19|4.1|4.4|4.3|3336|I Leukemias, myeloproliferative & myelodysplastic diseases|78112034|2003
0-19|4.1|4.4|4.3|3336|I Leukemias, myeloproliferative & myelodysplastic diseases|78112034|2003
0-14|0.0|0.0|0.0|16|VI(b) Renal carcinomas|58268801|2006
0-19|0.0|0.1|0.1|53|VI(b) Renal carcinomas|78718627|2006
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|73649093|2000
0-14|0.2|0.3|0.2|120|VII Hepatic tumors|55173748|2000
0-19|0.2|0.2|0.2|134|VII Hepatic tumors|73649093|2000
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|53943757|1999
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|71920580|1999
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|71920580|1999
0-14|0.2|0.3|0.2|112|VII Hepatic tumors|53943757|1999
0-19|0.2|0.2|0.2|144|VII Hepatic tumors|71920580|1999
0-14|0.1|0.2|0.2|438|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|274499921|2002-2006
0-19|0.1|0.2|0.1|549|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|368492797|2002-2006
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|56123816|2002
0-19|0.0|0.0|0.0|18|XI(a) Adrenocortical carcinomas|74939309|2002
0-14|0.5|0.6|0.5|305|II(a) Hodgkin lymphomas|56123816|2002
0-19|1.1|1.3|1.2|910|II(a) Hodgkin lymphomas|74939309|2002
0-19|1.1|1.3|1.2|910|II(a) Hodgkin lymphomas|74939309|2002
0-14|0.7|0.9|0.8|474|I(b) Acute myeloid leukemias|59678430|2004
0-19|0.8|0.9|0.8|661|I(b) Acute myeloid leukemias|79979457|2004
0-14|3.4|3.7|3.6|2074|I(a) Lymphoid leukemias|58431001|2003
0-19|2.9|3.2|3.0|2365|I(a) Lymphoid leukemias|78112034|2003
0-19|2.9|3.2|3.0|2365|I(a) Lymphoid leukemias|78112034|2003
0-19|0.2|0.2|0.2|144|VII Hepatic tumors|71920580|1999
0-19|0.7|0.9|0.8|566|IV(a) Neuroblastoma and ganglioneuroblastoma|71920580|1999
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|53943757|1999
0-19|0.0|0.0|0.0|19|IV(b) Other peripheral nervous cell tumors|71920580|1999
0-19|0.0|0.0|0.0|19|IV(b) Other peripheral nervous cell tumors|71920580|1999
0-19|0.1|0.1|0.1|53|VI(b) Renal carcinomas|78718627|2006
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|58268801|2006
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|78718627|2006
0-19|0.2|0.2|0.2|134|VII Hepatic tumors|73649093|2000
0-14|0.2|0.2|0.2|107|VII(a) Hepatoblastoma|55173748|2000
0-19|0.1|0.2|0.1|107|VII(a) Hepatoblastoma|73649093|2000
0-19|0.8|0.9|0.8|661|I(b) Acute myeloid leukemias|79979457|2004
0-14|0.1|0.2|0.1|88|I(c) Chronic myeloproliferative diseases|59678430|2004
0-19|0.2|0.2|0.2|152|I(c) Chronic myeloproliferative diseases|79979457|2004
0-19|0.0|0.0|0.0|18|XI(a) Adrenocortical carcinomas|74939309|2002
0-14|0.2|0.2|0.2|110|XI(b) Thyroid carcinomas|56123816|2002
0-19|0.5|0.6|0.6|427|XI(b) Thyroid carcinomas|74939309|2002
0-14|0.8|1.0|0.9|499|IX Soft tissue and other extraosseous sarcomas|53943757|1999
0-19|1.0|1.1|1.1|767|IX Soft tissue and other extraosseous sarcomas|71920580|1999
0-14|0.7|0.8|0.7|436|I(b) Acute myeloid leukemias|58431001|2003
0-19|0.7|0.8|0.8|603|I(b) Acute myeloid leukemias|78112034|2003
0-14|0.6|0.7|0.6|347|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|56123816|2002
0-19|0.8|0.9|0.8|617|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74939309|2002
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|78718627|2006
0-14|0.2|0.3|0.3|155|VII Hepatic tumors|58268801|2006
0-19|0.2|0.3|0.2|184|VII Hepatic tumors|78718627|2006
0-19|0.1|0.2|0.1|107|VII(a) Hepatoblastoma|73649093|2000
0-14|~|~|~|~|VII(b) Hepatic carcinomas|55173748|2000
0-19|0.0|0.1|0.0|27|VII(b) Hepatic carcinomas|73649093|2000
0-19|0.2|0.2|0.2|152|I(c) Chronic myeloproliferative diseases|79979457|2004
0-14|0.1|0.2|0.2|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59678430|2004
0-19|0.5|0.6|0.6|427|XI(b) Thyroid carcinomas|74939309|2002
0-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|56123816|2002
0-19|0.0|0.1|0.1|48|XI(c) Nasopharyngeal carcinomas|74939309|2002
0-19|1.0|1.1|1.1|767|IX Soft tissue and other extraosseous sarcomas|71920580|1999
0-14|0.4|0.5|0.5|260|IX(a) Rhabdomyosarcomas|53943757|1999
0-19|0.4|0.5|0.5|324|IX(a) Rhabdomyosarcomas|71920580|1999
0-19|0.7|0.8|0.8|603|I(b) Acute myeloid leukemias|78112034|2003
0-14|0.1|0.2|0.1|77|I(c) Chronic myeloproliferative diseases|58431001|2003
0-19|0.2|0.2|0.2|161|I(c) Chronic myeloproliferative diseases|78112034|2003
0-19|~|~|~|~|XI(e) Skin carcinomas|74878093|2001
0-14|0.1|0.2|0.2|98|XI(f) Other and unspecified carcinomas|56086557|2001
0-19|0.4|0.5|0.4|302|XI(f) Other and unspecified carcinomas|74878093|2001
0-19|0.2|0.3|0.2|184|VII Hepatic tumors|78718627|2006
0-14|0.2|0.2|0.2|126|VII(a) Hepatoblastoma|58268801|2006
0-19|0.1|0.2|0.2|127|VII(a) Hepatoblastoma|78718627|2006
0-19|0.0|0.1|0.0|27|VII(b) Hepatic carcinomas|73649093|2000
0-19|0.1|0.2|0.1|110|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|79979457|2004
0-19|0.1|0.2|0.1|110|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|79979457|2004
0-19|0.4|0.5|0.5|324|IX(a) Rhabdomyosarcomas|71920580|1999
0-14|0.1|0.1|0.1|52|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|53943757|1999
0-19|0.1|0.1|0.1|80|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|71920580|1999
0-19|0.0|0.1|0.1|48|XI(c) Nasopharyngeal carcinomas|74939309|2002
0-19|0.2|0.2|0.2|161|I(c) Chronic myeloproliferative diseases|78112034|2003
0-14|0.1|0.2|0.2|104|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|58431001|2003
0-19|0.4|0.5|0.4|302|XI(f) Other and unspecified carcinomas|74878093|2001
0-19|0.1|0.2|0.2|127|VII(a) Hepatoblastoma|78718627|2006
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|55173748|2000
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|73649093|2000
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|73649093|2000
0-14|0.1|0.2|0.1|83|I(e) Unspecified and other specified leukemias|59678430|2004
0-19|0.1|0.2|0.1|103|I(e) Unspecified and other specified leukemias|79979457|2004
0-19|0.1|0.2|0.1|103|I(e) Unspecified and other specified leukemias|79979457|2004
0-19|0.1|0.1|0.1|80|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|71920580|1999
0-14|~|~|~|~|IX(c) Kaposi sarcoma|53943757|1999
0-19|~|~|~|~|IX(c) Kaposi sarcoma|71920580|1999
0-19|~|~|~|~|IX(c) Kaposi sarcoma|71920580|1999
0-19|0.1|0.2|0.2|127|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78112034|2003
0-19|0.1|0.2|0.2|127|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|78112034|2003
0-14|0.2|0.3|0.2|132|XI(d) Malignant melanomas|56123816|2002
0-19|0.6|0.7|0.7|503|XI(d) Malignant melanomas|74939309|2002
0-19|0.6|0.7|0.7|503|XI(d) Malignant melanomas|74939309|2002
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|78718627|2006
0-14|0.9|1.1|1.0|595|IX Soft tissue and other extraosseous sarcomas|58268801|2006
0-19|1.1|1.2|1.1|899|IX Soft tissue and other extraosseous sarcomas|78718627|2006
0-19|0.4|0.5|0.5|355|IX(a) Rhabdomyosarcomas|73649093|2000
0-14|1.5|1.7|1.6|964|II Lymphomas and reticuloendothelial neoplasms|59678430|2004
0-19|2.3|2.5|2.4|1937|II Lymphomas and reticuloendothelial neoplasms|79979457|2004
0-14|0.1|0.1|0.1|56|I(e) Unspecified and other specified leukemias|58431001|2003
0-19|0.1|0.1|0.1|80|I(e) Unspecified and other specified leukemias|78112034|2003
0-19|0.1|0.1|0.1|80|I(e) Unspecified and other specified leukemias|78112034|2003
0-14|0.2|0.3|0.2|134|IX(d) Other specified soft tissue sarcomas|53943757|1999
0-19|0.3|0.4|0.4|270|IX(d) Other specified soft tissue sarcomas|71920580|1999
0-19|0.3|0.4|0.4|270|IX(d) Other specified soft tissue sarcomas|71920580|1999
0-14|~|~|~|~|XI(e) Skin carcinomas|56123816|2002
0-19|~|~|~|~|XI(e) Skin carcinomas|74939309|2002
0-19|~|~|~|~|XI(e) Skin carcinomas|74939309|2002
0-14|0.0|0.1|0.1|31|XII Other and unspecified malignant neoplasms|56086557|2001
0-19|0.1|0.1|0.1|51|XII Other and unspecified malignant neoplasms|74878093|2001
0-19|0.1|0.1|0.1|51|XII Other and unspecified malignant neoplasms|74878093|2001
0-14|0.0|0.1|0.0|20|XII(a) Other specified malignant tumors|56086557|2001
0-19|0.0|0.1|0.0|28|XII(a) Other specified malignant tumors|74878093|2001
0-19|0.0|0.1|0.0|28|XII(a) Other specified malignant tumors|74878093|2001
0-14|0.1|0.1|0.1|52|IX(e) Unspecified soft tissue sarcomas|53943757|1999
0-19|0.1|0.2|0.1|90|IX(e) Unspecified soft tissue sarcomas|71920580|1999
0-19|0.2|0.3|0.3|183|III(a) Ependymomas and choroid plexus tumor|71920580|1999
0-19|1.1|1.2|1.1|899|IX Soft tissue and other extraosseous sarcomas|78718627|2006
0-14|0.4|0.5|0.5|272|IX(a) Rhabdomyosarcomas|58268801|2006
0-19|0.4|0.5|0.4|351|IX(a) Rhabdomyosarcomas|78718627|2006
0-14|0.0|0.0|0.0|77|XI(c) Nasopharyngeal carcinomas|274499921|2002-2006
0-19|0.1|0.1|0.1|221|XI(c) Nasopharyngeal carcinomas|368492797|2002-2006
0-19|2.3|2.5|2.4|1937|II Lymphomas and reticuloendothelial neoplasms|79979457|2004
0-14|0.5|0.6|0.5|316|II(a) Hodgkin lymphomas|59678430|2004
0-19|1.1|1.3|1.2|954|II(a) Hodgkin lymphomas|79979457|2004
0-14|0.1|0.1|0.1|51|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|55173748|2000
0-19|0.1|0.1|0.1|87|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|73649093|2000
0-19|0.1|0.1|0.1|87|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|73649093|2000
0-14|1.3|1.5|1.4|755|III(b) Astrocytomas|53943757|1999
0-19|1.2|1.4|1.3|954|III(b) Astrocytomas|71920580|1999
0-14|0.1|0.2|0.2|99|XI(f) Other and unspecified carcinomas|56123816|2002
0-19|0.4|0.4|0.4|302|XI(f) Other and unspecified carcinomas|74939309|2002
0-19|0.4|0.5|0.4|302|XI(f) Other and unspecified carcinomas|74939309|2002
0-19|0.4|0.5|0.4|351|IX(a) Rhabdomyosarcomas|78718627|2006
0-19|1.2|1.4|1.3|954|III(b) Astrocytomas|71920580|1999
0-14|0.7|0.9|0.8|436|III(c) Intracranial and intraspinal embryonal tumors|53943757|1999
0-19|0.6|0.7|0.7|493|III(c) Intracranial and intraspinal embryonal tumors|71920580|1999
0-14|~|~|~|~|XII(b) Other unspecified malignant tumors|56086557|2001
0-19|0.0|0.0|0.0|23|XII(b) Other unspecified malignant tumors|74878093|2001
0-19|0.1|0.1|0.1|243|XI(c) Nasopharyngeal carcinomas|408000943|2002-2006
0-14|0.2|0.3|0.2|646|XI(d) Malignant melanomas|274499921|2002-2006
0-19|0.6|0.7|0.6|2326|XI(d) Malignant melanomas|368492797|2002-2006
0-14|~|~|~|~|IX(c) Kaposi sarcoma|55173748|2000
0-19|~|~|~|~|IX(c) Kaposi sarcoma|73649093|2000
0-19|~|~|~|~|IX(c) Kaposi sarcoma|73649093|2000
0-19|0.6|0.7|0.7|493|III(c) Intracranial and intraspinal embryonal tumors|71920580|1999
0-14|0.4|0.6|0.5|274|III(d) Other gliomas|53943757|1999
0-19|0.4|0.5|0.5|333|III(d) Other gliomas|71920580|1999
0-14|0.3|0.4|0.3|173|IX(d) Other specified soft tissue sarcomas|55173748|2000
0-19|0.4|0.5|0.4|325|IX(d) Other specified soft tissue sarcomas|73649093|2000
0-19|0.6|0.6|0.6|2520|XI(d) Malignant melanomas|408000943|2002-2006
0-14|0.0|0.0|0.0|19|XI(e) Skin carcinomas|274499921|2002-2006
0-19|0.0|0.0|0.0|31|XI(e) Skin carcinomas|368492797|2002-2006
0-19|0.4|0.5|0.5|333|III(d) Other gliomas|71920580|1999
0-19|1.1|1.3|1.2|954|II(a) Hodgkin lymphomas|79979457|2004
0-14|0.6|0.8|0.7|411|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59678430|2004
0-19|0.8|0.9|0.9|683|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|79979457|2004
0-19|0.4|0.5|0.4|325|IX(d) Other specified soft tissue sarcomas|73649093|2000
0-14|0.1|0.1|0.1|59|IX(e) Unspecified soft tissue sarcomas|55173748|2000
0-19|0.1|0.2|0.1|99|IX(e) Unspecified soft tissue sarcomas|73649093|2000
0-19|0.1|0.2|0.1|99|IX(e) Unspecified soft tissue sarcomas|73649093|2000
0-14|~|~|~|~|Not classified by ICCC|55173748|2000
0-19|0.0|0.0|0.0|18|Not classified by ICCC|73649093|2000
0-19|0.0|0.0|0.0|35|XI(e) Skin carcinomas|408000943|2002-2006
0-19|~|~|~|~|XI(e) Skin carcinomas|78112034|2003
0-14|0.1|0.1|0.1|66|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|58268801|2006
0-19|0.1|0.2|0.1|102|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78718627|2006
0-19|0.1|0.2|0.1|102|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|78718627|2006
0-14|0.0|0.1|0.1|27|III(e) Other specified intracranial & intraspinal neoplasms|53943757|1999
0-19|0.0|0.1|0.1|36|III(e) Other specified intracranial & intraspinal neoplasms|71920580|1999
0-19|0.0|0.1|0.1|36|III(e) Other specified intracranial & intraspinal neoplasms|71920580|1999
0-14|0.0|0.1|0.1|36|III(f) Unspecified intracranial and intraspinal neoplasms|53943757|1999
0-19|0.0|0.1|0.1|41|III(f) Unspecified intracranial and intraspinal neoplasms|71920580|1999
0-19|0.0|0.1|0.1|41|III(f) Unspecified intracranial and intraspinal neoplasms|71920580|1999
0-19|0.0|0.0|0.0|18|Not classified by ICCC|73649093|2000
0-14|0.1|0.2|0.2|107|XI(f) Other and unspecified carcinomas|58431001|2003
0-19|0.4|0.5|0.4|332|XI(f) Other and unspecified carcinomas|78112034|2003
0-19|0.4|0.5|0.4|332|XI(f) Other and unspecified carcinomas|78112034|2003
0-14|0.0|0.1|0.1|32|XII Other and unspecified malignant neoplasms|56123816|2002
0-19|0.1|0.1|0.1|58|XII Other and unspecified malignant neoplasms|74939309|2002
0-14|1.0|1.1|1.1|567|IV Neuroblastoma and other peripheral nervous cell tumors|53943757|1999
0-19|0.8|0.9|0.8|585|IV Neuroblastoma and other peripheral nervous cell tumors|71920580|1999
0-14|~|~|~|~|IX(c) Kaposi sarcoma|58268801|2006
0-19|~|~|~|~|IX(c) Kaposi sarcoma|78718627|2006
0-19|~|~|~|~|IX(c) Kaposi sarcoma|78718627|2006
0-14|0.2|0.2|0.2|497|XI(f) Other and unspecified carcinomas|274499921|2002-2006
0-19|0.4|0.4|0.4|1536|XI(f) Other and unspecified carcinomas|368492797|2002-2006
0-19|0.4|0.4|0.4|1677|XI(f) Other and unspecified carcinomas|408000943|2002-2006
0-14|0.4|0.5|0.4|232|V Retinoblastoma|55173748|2000
0-19|0.3|0.4|0.3|233|V Retinoblastoma|73649093|2000
0-19|0.3|0.4|0.3|233|V Retinoblastoma|73649093|2000
0-14|0.1|0.1|0.1|44|XII Other and unspecified malignant neoplasms|58431001|2003
0-19|0.1|0.1|0.1|78|XII Other and unspecified malignant neoplasms|78112034|2003
0-19|0.1|0.1|0.1|78|XII Other and unspecified malignant neoplasms|78112034|2003
0-19|0.1|0.1|0.1|58|XII Other and unspecified malignant neoplasms|74939309|2002
0-14|0.0|0.1|0.0|20|XII(a) Other specified malignant tumors|56123816|2002
0-19|0.0|0.1|0.0|35|XII(a) Other specified malignant tumors|74939309|2002
0-14|0.5|0.6|0.5|311|X Germ cell, trophoblastic tumors & neoplasms of gonads|56123816|2002
0-19|1.0|1.2|1.1|841|X Germ cell, trophoblastic tumors & neoplasms of gonads|74939309|2002
0-19|0.7|0.9|0.8|585|IV Neuroblastoma and other peripheral nervous cell tumors|71920580|1999
0-14|1.0|1.1|1.0|559|IV(a) Neuroblastoma and ganglioneuroblastoma|53943757|1999
0-19|0.0|0.0|0.0|23|XII(b) Other unspecified malignant tumors|74878093|2001
0-14|15.0|15.7|15.4|8629|All ICCC Groups Combined|56123816|2002
0-19|16.6|17.2|16.9|12667|All ICCC Groups Combined|74939309|2002
0-14|0.3|0.4|0.3|195|IX(d) Other specified soft tissue sarcomas|58268801|2006
0-19|0.4|0.5|0.4|347|IX(d) Other specified soft tissue sarcomas|78718627|2006
0-14|0.1|0.1|0.1|184|XII Other and unspecified malignant neoplasms|274499921|2002-2006
0-19|0.1|0.1|0.1|317|XII Other and unspecified malignant neoplasms|368492797|2002-2006
0-19|0.1|0.1|0.1|332|XII Other and unspecified malignant neoplasms|408000943|2002-2006
0-19|16.6|17.2|16.9|12667|All ICCC Groups Combined|74939309|2002
0-14|4.7|5.1|4.9|2739|I Leukemias, myeloproliferative & myelodysplastic diseases|56123816|2002
0-19|4.3|4.6|4.4|3323|I Leukemias, myeloproliferative & myelodysplastic diseases|74939309|2002
0-14|0.0|0.1|0.0|19|XII(a) Other specified malignant tumors|58431001|2003
0-19|0.0|0.1|0.0|36|XII(a) Other specified malignant tumors|78112034|2003
0-19|0.7|0.9|0.8|566|IV(a) Neuroblastoma and ganglioneuroblastoma|71920580|1999
0-19|2.2|2.4|2.3|1673|II Lymphomas and reticuloendothelial neoplasms|71920580|1999
0-14|0.8|0.9|0.9|467|VI Renal tumors|55173748|2000
0-19|0.6|0.7|0.7|486|VI Renal tumors|73649093|2000
0-19|0.6|0.7|0.7|486|VI Renal tumors|73649093|2000
0-19|0.4|0.5|0.4|321|III(d) Other gliomas|73649093|2000
0-14|0.5|0.6|0.5|293|II(a) Hodgkin lymphomas|53943757|1999
0-19|1.1|1.3|1.2|849|II(a) Hodgkin lymphomas|71920580|1999
0-19|1.1|1.3|1.2|849|II(a) Hodgkin lymphomas|71920580|1999
0-19|0.0|0.1|0.0|36|XII(a) Other specified malignant tumors|78112034|2003
0-14|0.0|0.1|0.0|25|XII(b) Other unspecified malignant tumors|58431001|2003
0-19|0.0|0.1|0.1|42|XII(b) Other unspecified malignant tumors|78112034|2003
0-14|0.0|0.0|0.0|97|XII(a) Other specified malignant tumors|274499921|2002-2006
0-19|0.0|0.0|0.0|158|XII(a) Other specified malignant tumors|368492797|2002-2006
0-19|1.0|1.2|1.1|841|X Germ cell, trophoblastic tumors & neoplasms of gonads|74939309|2002
0-19|0.4|0.5|0.4|347|IX(d) Other specified soft tissue sarcomas|78718627|2006
0-14|0.1|0.1|0.1|60|IX(e) Unspecified soft tissue sarcomas|58268801|2006
0-19|0.1|0.1|0.1|96|IX(e) Unspecified soft tissue sarcomas|78718627|2006
0-14|0.0|0.1|0.0|24|III(e) Other specified intracranial & intraspinal neoplasms|55173748|2000
0-19|0.0|0.1|0.0|32|III(e) Other specified intracranial & intraspinal neoplasms|73649093|2000
0-19|0.0|0.1|0.0|32|III(e) Other specified intracranial & intraspinal neoplasms|73649093|2000
0-14|0.1|0.1|0.1|39|III(f) Unspecified intracranial and intraspinal neoplasms|55173748|2000
0-19|0.0|0.1|0.1|48|III(f) Unspecified intracranial and intraspinal neoplasms|73649093|2000
0-19|0.0|0.1|0.1|48|III(f) Unspecified intracranial and intraspinal neoplasms|73649093|2000
0-14|0.9|1.1|1.0|540|IV Neuroblastoma and other peripheral nervous cell tumors|55173748|2000
0-19|0.7|0.8|0.7|548|IV Neuroblastoma and other peripheral nervous cell tumors|73649093|2000
0-14|0.5|0.7|0.6|327|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|53943757|1999
0-19|0.7|0.8|0.8|551|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|71920580|1999
0-19|0.7|0.8|0.8|551|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|71920580|1999
0-19|0.0|0.1|0.1|42|XII(b) Other unspecified malignant tumors|78112034|2003
0-14|15.4|16.0|15.7|9445|All ICCC Groups Combined|59678430|2004
0-19|16.9|17.5|17.2|13823|All ICCC Groups Combined|79979457|2004
0-19|0.0|0.0|0.0|169|XII(a) Other specified malignant tumors|408000943|2002-2006
0-14|0.0|0.0|0.0|87|XII(b) Other unspecified malignant tumors|274499921|2002-2006
0-19|0.0|0.0|0.0|159|XII(b) Other unspecified malignant tumors|368492797|2002-2006
0-19|0.1|0.1|0.1|96|IX(e) Unspecified soft tissue sarcomas|78718627|2006
0-14|~|~|~|~|Not classified by ICCC|58268801|2006
0-19|0.0|0.0|0.0|25|Not classified by ICCC|78718627|2006
0-14|0.1|0.2|0.2|85|X(a) Intracranial & intraspinal germ cell tumors|56123816|2002
0-19|0.1|0.2|0.2|128|X(a) Intracranial & intraspinal germ cell tumors|74939309|2002
0-19|0.1|0.2|0.2|128|X(a) Intracranial & intraspinal germ cell tumors|74939309|2002
0-19|0.0|0.0|0.0|163|XII(b) Other unspecified malignant tumors|408000943|2002-2006
0-14|0.1|0.2|0.1|411|X(b) Malignant extracranial & extragonadal germ cell tumors|274499921|2002-2006
0-19|0.1|0.2|0.1|556|X(b) Malignant extracranial & extragonadal germ cell tumors|368492797|2002-2006
0-14|0.2|0.3|0.3|138|II(c) Burkitt lymphoma|53943757|1999
0-19|0.2|0.3|0.2|175|II(c) Burkitt lymphoma|71920580|1999
0-19|4.3|4.6|4.4|3323|I Leukemias, myeloproliferative & myelodysplastic diseases|74939309|2002
0-19|17.0|17.6|17.3|13823|All ICCC Groups Combined|79979457|2004
0-19|0.7|0.8|0.7|548|IV Neuroblastoma and other peripheral nervous cell tumors|73649093|2000
0-14|3.5|3.8|3.7|2044|I(a) Lymphoid leukemias|56123816|2002
0-19|3.0|3.3|3.1|2350|I(a) Lymphoid leukemias|74939309|2002
0-14|~|~|~|~|X(d) Gonadal carcinomas|56086557|2001
0-19|0.0|0.0|0.0|25|X(d) Gonadal carcinomas|74878093|2001
0-19|0.0|0.0|0.0|25|X(d) Gonadal carcinomas|74878093|2001
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|56086557|2001
0-19|0.0|0.0|0.0|20|X(e) Other and unspecified malignant gonadal tumors|74878093|2001
0-19|1.3|1.5|1.4|1107|III(b) Astrocytomas|78718627|2006
0-14|0.7|0.8|0.7|432|III(c) Intracranial and intraspinal embryonal tumors|58268801|2006
0-19|0.6|0.7|0.6|479|III(c) Intracranial and intraspinal embryonal tumors|78718627|2006
0-14|4.8|5.2|5.0|3011|I Leukemias, myeloproliferative & myelodysplastic diseases|59678430|2004
0-19|4.4|4.7|4.5|3638|I Leukemias, myeloproliferative & myelodysplastic diseases|79979457|2004
0-19|4.4|4.7|4.5|3638|I Leukemias, myeloproliferative & myelodysplastic diseases|79979457|2004
0-14|0.9|1.1|1.0|534|IV(a) Neuroblastoma and ganglioneuroblastoma|55173748|2000
0-19|0.7|0.8|0.7|540|IV(a) Neuroblastoma and ganglioneuroblastoma|73649093|2000
0-19|0.7|0.8|0.7|540|IV(a) Neuroblastoma and ganglioneuroblastoma|73649093|2000
0-14|0.1|0.2|0.2|87|X(b) Malignant extracranial & extragonadal germ cell tumors|56123816|2002
0-19|0.1|0.2|0.2|123|X(b) Malignant extracranial & extragonadal germ cell tumors|74939309|2002
0-19|0.1|0.2|0.2|624|X(b) Malignant extracranial & extragonadal germ cell tumors|408000943|2002-2006
0-19|0.2|0.3|0.2|175|II(c) Burkitt lymphoma|71920580|1999
0-14|0.1|0.1|0.1|53|II(d) Miscellaneous lymphoreticular neoplasms|53943757|1999
0-19|0.1|0.1|0.1|55|II(d) Miscellaneous lymphoreticular neoplasms|71920580|1999
0-19|0.0|0.0|0.0|20|X(e) Other and unspecified malignant gonadal tumors|74878093|2001
0-14|0.6|0.8|0.7|385|XI Other malignant epithelial neoplasms and malignant melanomas|56086557|2001
0-19|1.6|1.7|1.7|1238|XI Other malignant epithelial neoplasms and malignant melanomas|74878093|2001
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|55173748|2000
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|73649093|2000
0-19|0.6|0.7|0.6|479|III(c) Intracranial and intraspinal embryonal tumors|78718627|2006
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|73649093|2000
0-14|1.0|1.1|1.0|571|IX Soft tissue and other extraosseous sarcomas|55173748|2000
0-19|1.1|1.3|1.2|870|IX Soft tissue and other extraosseous sarcomas|73649093|2000
0-19|0.1|0.2|0.2|123|X(b) Malignant extracranial & extragonadal germ cell tumors|74939309|2002
0-14|0.2|0.3|0.2|130|X(c) Malignant gonadal germ cell tumors|56123816|2002
0-19|0.7|0.8|0.7|548|X(c) Malignant gonadal germ cell tumors|74939309|2002
0-14|0.2|0.3|0.2|646|X(c) Malignant gonadal germ cell tumors|274499921|2002-2006
0-19|0.7|0.7|0.7|2674|X(c) Malignant gonadal germ cell tumors|368492797|2002-2006
0-19|0.7|0.8|0.7|2986|X(c) Malignant gonadal germ cell tumors|408000943|2002-2006
0-19|0.1|0.1|0.1|55|II(d) Miscellaneous lymphoreticular neoplasms|71920580|1999
0-14|0.0|0.1|0.0|23|II(e) Unspecified lymphomas|53943757|1999
0-19|0.0|0.1|0.1|43|II(e) Unspecified lymphomas|71920580|1999
0-19|1.6|1.7|1.7|1238|XI Other malignant epithelial neoplasms and malignant melanomas|74878093|2001
0-19|1.1|1.3|1.2|870|IX Soft tissue and other extraosseous sarcomas|73649093|2000
0-14|0.5|0.6|0.5|287|IX(a) Rhabdomyosarcomas|55173748|2000
0-19|0.4|0.5|0.5|355|IX(a) Rhabdomyosarcomas|73649093|2000
0-14|0.4|0.6|0.5|292|III(d) Other gliomas|58268801|2006
0-19|0.4|0.5|0.5|381|III(d) Other gliomas|78718627|2006
0-19|0.4|0.5|0.5|381|III(d) Other gliomas|78718627|2006
0-14|0.0|0.0|0.0|29|X(d) Gonadal carcinomas|274499921|2002-2006
0-19|0.0|0.0|0.0|142|X(d) Gonadal carcinomas|368492797|2002-2006
0-19|0.0|0.0|0.0|163|X(d) Gonadal carcinomas|408000943|2002-2006
0-19|0.7|0.8|0.7|548|X(c) Malignant gonadal germ cell tumors|74939309|2002
0-14|~|~|~|~|X(d) Gonadal carcinomas|56123816|2002
0-19|0.0|0.0|0.0|20|X(d) Gonadal carcinomas|74939309|2002
0-19|0.0|0.1|0.1|43|II(e) Unspecified lymphomas|71920580|1999
0-19|0.2|0.3|0.3|200|II(c) Burkitt lymphoma|73649093|2000
0-14|0.1|0.2|0.1|72|II(d) Miscellaneous lymphoreticular neoplasms|55173748|2000
0-19|0.1|0.1|0.1|75|II(d) Miscellaneous lymphoreticular neoplasms|73649093|2000
0-14|3.0|3.3|3.1|1683|III CNS and misc intracranial and intraspinal neoplasms|53943757|1999
0-19|2.7|3.0|2.8|2040|III CNS and misc intracranial and intraspinal neoplasms|71920580|1999
0-19|2.7|3.0|2.8|2040|III CNS and misc intracranial and intraspinal neoplasms|71920580|1999
0-14|0.0|0.1|0.0|29|III(e) Other specified intracranial & intraspinal neoplasms|58268801|2006
0-19|0.0|0.1|0.1|44|III(e) Other specified intracranial & intraspinal neoplasms|78718627|2006
0-19|0.0|0.1|0.1|44|III(e) Other specified intracranial & intraspinal neoplasms|78718627|2006
0-14|0.2|0.3|0.3|155|III(a) Ependymomas and choroid plexus tumor|53943757|1999
0-19|0.2|0.3|0.3|183|III(a) Ependymomas and choroid plexus tumor|71920580|1999
0-19|15.6|16.1|15.9|11401|All ICCC Groups Combined|71920580|1999
0-14|~|~|~|~|XI(a) Adrenocortical carcinomas|56086557|2001
0-19|0.0|0.0|0.0|16|XI(a) Adrenocortical carcinomas|74878093|2001
0-19|0.0|0.0|0.0|16|XI(a) Adrenocortical carcinomas|74878093|2001
0-14|0.0|0.0|0.0|37|X(e) Other and unspecified malignant gonadal tumors|274499921|2002-2006
0-19|0.0|0.0|0.0|117|X(e) Other and unspecified malignant gonadal tumors|368492797|2002-2006
0-19|0.0|0.0|0.0|20|X(d) Gonadal carcinomas|74939309|2002
0-19|0.1|0.1|0.1|75|II(d) Miscellaneous lymphoreticular neoplasms|73649093|2000
0-14|0.0|0.1|0.1|35|II(e) Unspecified lymphomas|55173748|2000
0-19|0.1|0.1|0.1|50|II(e) Unspecified lymphomas|73649093|2000
0-19|0.1|0.1|0.1|50|II(e) Unspecified lymphomas|73649093|2000
0-14|4.4|4.8|4.6|2490|I Leukemias, myeloproliferative & myelodysplastic diseases|53943757|1999
0-19|4.0|4.3|4.1|2978|I Leukemias, myeloproliferative & myelodysplastic diseases|71920580|1999
0-14|0.1|0.1|0.1|41|III(f) Unspecified intracranial and intraspinal neoplasms|58268801|2006
0-19|0.0|0.1|0.1|50|III(f) Unspecified intracranial and intraspinal neoplasms|78718627|2006
0-14|3.1|3.4|3.3|1794|III CNS and misc intracranial and intraspinal neoplasms|55173748|2000
0-19|2.9|3.1|3.0|2191|III CNS and misc intracranial and intraspinal neoplasms|73649093|2000
0-19|2.9|3.1|3.0|2191|III CNS and misc intracranial and intraspinal neoplasms|73649093|2000
0-19|0.1|0.1|0.1|93|II(d) Miscellaneous lymphoreticular neoplasms|80201013|2005
0-14|3.6|4.0|3.8|2274|I(a) Lymphoid leukemias|59678430|2004
0-19|3.1|3.4|3.3|2612|I(a) Lymphoid leukemias|79979457|2004
0-19|0.0|0.0|0.0|123|X(e) Other and unspecified malignant gonadal tumors|408000943|2002-2006
0-14|0.7|0.7|0.7|1931|XI Other malignant epithelial neoplasms and malignant melanomas|274499921|2002-2006
0-19|1.7|1.8|1.8|6544|XI Other malignant epithelial neoplasms and malignant melanomas|368492797|2002-2006
0-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|56123816|2002
0-19|0.0|0.0|0.0|22|X(e) Other and unspecified malignant gonadal tumors|74939309|2002
0-19|0.0|0.0|0.0|22|X(e) Other and unspecified malignant gonadal tumors|74939309|2002
0-14|0.2|0.3|0.2|135|XI(b) Thyroid carcinomas|56086557|2001
0-19|0.5|0.6|0.6|438|XI(b) Thyroid carcinomas|74878093|2001
0-19|0.5|0.6|0.6|438|XI(b) Thyroid carcinomas|74878093|2001
0-19|4.0|4.3|4.1|2978|I Leukemias, myeloproliferative & myelodysplastic diseases|71920580|1999
0-14|3.5|3.8|3.6|1961|I(a) Lymphoid leukemias|53943757|1999
0-19|3.0|3.2|3.1|2218|I(a) Lymphoid leukemias|71920580|1999
0-19|0.0|0.1|0.1|50|III(f) Unspecified intracranial and intraspinal neoplasms|78718627|2006
0-14|0.9|1.1|1.0|590|IV Neuroblastoma and other peripheral nervous cell tumors|58268801|2006
0-19|0.7|0.8|0.7|604|IV Neuroblastoma and other peripheral nervous cell tumors|78718627|2006
0-19|1.7|1.8|1.7|7129|XI Other malignant epithelial neoplasms and malignant melanomas|408000943|2002-2006
0-14|0.6|0.7|0.7|374|XI Other malignant epithelial neoplasms and malignant melanomas|56123816|2002
0-19|1.6|1.8|1.7|1306|XI Other malignant epithelial neoplasms and malignant melanomas|74939309|2002
0-19|1.6|1.8|1.7|1306|XI Other malignant epithelial neoplasms and malignant melanomas|74939309|2002
0-14|0.0|0.1|0.0|19|XI(c) Nasopharyngeal carcinomas|56086557|2001
0-19|0.0|0.1|0.1|44|XI(c) Nasopharyngeal carcinomas|74878093|2001
0-19|0.0|0.1|0.1|44|XI(c) Nasopharyngeal carcinomas|74878093|2001
0-19|3.0|3.2|3.1|2218|I(a) Lymphoid leukemias|71920580|1999
0-19|0.7|0.8|0.8|604|IV Neuroblastoma and other peripheral nervous cell tumors|78718627|2006
0-14|0.0|0.0|0.0|60|XI(a) Adrenocortical carcinomas|274499921|2002-2006
0-19|0.0|0.0|0.0|77|XI(a) Adrenocortical carcinomas|368492797|2002-2006
0-19|0.0|0.0|0.0|88|XI(a) Adrenocortical carcinomas|408000943|2002-2006
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|56123816|2002
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74939309|2002
0-14|0.2|0.2|0.2|115|XI(d) Malignant melanomas|56086557|2001
0-19|0.5|0.6|0.6|434|XI(d) Malignant melanomas|74878093|2001
0-14|0.7|0.8|0.8|414|I(b) Acute myeloid leukemias|53943757|1999
0-19|0.8|0.9|0.8|586|I(b) Acute myeloid leukemias|71920580|1999
0-19|0.8|0.9|0.8|586|I(b) Acute myeloid leukemias|71920580|1999
0-14|0.2|0.2|0.2|632|XI(b) Thyroid carcinomas|274499921|2002-2006
0-19|0.6|0.7|0.6|2353|XI(b) Thyroid carcinomas|368492797|2002-2006
0-19|0.6|0.7|0.6|2566|XI(b) Thyroid carcinomas|408000943|2002-2006
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74939309|2002
0-14|0.6|0.8|0.7|388|VIII Malignant bone tumors|56123816|2002
0-19|0.8|1.0|0.9|683|VIII Malignant bone tumors|74939309|2002
0-14|0.0|0.1|0.1|32|I(c) Chronic myeloproliferative diseases|53943757|1999
0-19|0.1|0.1|0.1|70|I(c) Chronic myeloproliferative diseases|71920580|1999
0-19|0.1|0.1|0.1|70|I(c) Chronic myeloproliferative diseases|71920580|1999
0-19|0.5|0.6|0.6|434|XI(d) Malignant melanomas|74878093|2001
0-14|~|~|~|~|XI(e) Skin carcinomas|56086557|2001
0-19|~|~|~|~|XI(e) Skin carcinomas|74878093|2001
0-19|0.3|0.4|0.3|248|VIII(c) Ewing tumor and related sarcomas of bone|74878093|2001
0-14|0.4|0.4|0.4|1070|VIII(a) Osteosarcomas|274499921|2002-2006
0-19|0.5|0.5|0.5|1910|VIII(a) Osteosarcomas|368492797|2002-2006
0-19|0.5|0.5|0.5|2123|VIII(a) Osteosarcomas|408000943|2002-2006
0-19|0.8|1.0|0.9|683|VIII Malignant bone tumors|74939309|2002
0-14|0.3|0.4|0.4|209|VIII(a) Osteosarcomas|56123816|2002
0-19|0.4|0.5|0.5|372|VIII(a) Osteosarcomas|74939309|2002
0-19|0.3|0.4|0.3|248|VIII(c) Ewing tumor and related sarcomas of bone|74878093|2001
0-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|56086557|2001
0-19|0.0|0.1|0.0|30|VIII(d) Other specified malignant bone tumors|74878093|2001
0-19|0.4|0.5|0.5|372|VIII(a) Osteosarcomas|74939309|2002
0-14|~|~|~|~|VIII(b) Chondrosarcomas|56123816|2002
0-19|0.0|0.1|0.0|35|VIII(b) Chondrosarcomas|74939309|2002
0-19|0.0|0.1|0.0|35|VIII(b) Chondrosarcomas|74939309|2002
0-19|0.0|0.1|0.0|30|VIII(d) Other specified malignant bone tumors|74878093|2001
0-14|0.2|0.3|0.3|143|VIII(c) Ewing tumor and related sarcomas of bone|56123816|2002
0-19|0.3|0.3|0.3|226|VIII(c) Ewing tumor and related sarcomas of bone|74939309|2002
0-19|0.3|0.3|0.3|226|VIII(c) Ewing tumor and related sarcomas of bone|74939309|2002
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|56086557|2001
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|74878093|2001
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|74878093|2001
0-14|0.0|0.1|0.0|21|VIII(d) Other specified malignant bone tumors|56123816|2002
0-19|0.0|0.1|0.1|39|VIII(d) Other specified malignant bone tumors|74939309|2002
0-14|0.4|0.6|0.5|287|X Germ cell, trophoblastic tumors & neoplasms of gonads|56086557|2001
0-19|1.0|1.1|1.0|783|X Germ cell, trophoblastic tumors & neoplasms of gonads|74878093|2001
0-19|1.0|1.1|1.0|783|X Germ cell, trophoblastic tumors & neoplasms of gonads|74878093|2001
0-19|0.0|0.1|0.1|39|VIII(d) Other specified malignant bone tumors|74939309|2002
0-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|56123816|2002
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|74939309|2002
0-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|74939309|2002
0-14|0.1|0.2|0.1|74|X(a) Intracranial & intraspinal germ cell tumors|56086557|2001
0-19|0.1|0.2|0.2|121|X(a) Intracranial & intraspinal germ cell tumors|74878093|2001
0-19|0.2|0.3|0.3|209|V Retinoblastoma|74939309|2002
0-14|0.8|0.9|0.8|462|VI Renal tumors|56123816|2002
0-19|0.6|0.7|0.6|485|VI Renal tumors|74939309|2002
0-19|0.1|0.2|0.2|121|X(a) Intracranial & intraspinal germ cell tumors|74878093|2001
0-14|0.1|0.2|0.1|80|X(b) Malignant extracranial & extragonadal germ cell tumors|56086557|2001
0-19|0.1|0.2|0.2|121|X(b) Malignant extracranial & extragonadal germ cell tumors|74878093|2001
0-19|0.6|0.7|0.6|485|VI Renal tumors|74939309|2002
0-14|0.7|0.9|0.8|450|VI(a) Nephroblastoma and other nonepithelial renal tumors|56123816|2002
0-19|0.6|0.7|0.6|453|VI(a) Nephroblastoma and other nonepithelial renal tumors|74939309|2002
0-19|0.1|0.2|0.2|121|X(b) Malignant extracranial & extragonadal germ cell tumors|74878093|2001
0-19|0.6|0.7|0.6|453|VI(a) Nephroblastoma and other nonepithelial renal tumors|74939309|2002
0-14|0.2|0.2|0.2|116|X(c) Malignant gonadal germ cell tumors|56086557|2001
0-19|0.6|0.7|0.7|496|X(c) Malignant gonadal germ cell tumors|74878093|2001
0-19|0.6|0.7|0.7|496|X(c) Malignant gonadal germ cell tumors|74878093|2001
0-14|0.2|0.2|0.2|117|VII Hepatic tumors|56086557|2001
0-19|0.2|0.2|0.2|136|VII Hepatic tumors|74878093|2001
0-19|0.2|0.2|0.2|136|VII Hepatic tumors|74878093|2001
0-14|0.1|0.2|0.2|95|VII(a) Hepatoblastoma|56086557|2001
0-19|0.1|0.2|0.1|96|VII(a) Hepatoblastoma|74878093|2001
0-19|0.1|0.2|0.1|96|VII(a) Hepatoblastoma|74878093|2001
0-14|0.0|0.1|0.0|21|VII(b) Hepatic carcinomas|56086557|2001
0-19|0.0|0.1|0.1|39|VII(b) Hepatic carcinomas|74878093|2001
0-19|0.0|0.1|0.1|39|VII(b) Hepatic carcinomas|74878093|2001
0-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|56086557|2001
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74878093|2001
0-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74878093|2001
0-14|0.6|0.8|0.7|386|VIII Malignant bone tumors|56086557|2001
0-19|0.9|1.0|0.9|700|VIII Malignant bone tumors|74878093|2001
0-19|0.9|1.0|0.9|700|VIII Malignant bone tumors|74878093|2001
0-14|0.3|0.4|0.4|212|VIII(a) Osteosarcomas|56086557|2001
0-19|0.5|0.6|0.5|385|VIII(a) Osteosarcomas|74878093|2001
0-19|0.5|0.6|0.5|385|VIII(a) Osteosarcomas|74878093|2001
0-14|~|~|~|~|VIII(b) Chondrosarcomas|56086557|2001
0-19|0.0|0.1|0.0|26|VIII(b) Chondrosarcomas|74878093|2001
0-19|0.0|0.1|0.0|26|VIII(b) Chondrosarcomas|74878093|2001
0-14|0.2|0.3|0.3|149|VIII(c) Ewing tumor and related sarcomas of bone|56086557|2001
0-19|0.4|0.5|0.4|306|IX(d) Other specified soft tissue sarcomas|74878093|2001
0-14|0.1|0.1|0.1|56|IX(e) Unspecified soft tissue sarcomas|56086557|2001
0-19|0.1|0.1|0.1|92|IX(e) Unspecified soft tissue sarcomas|74878093|2001
0-19|0.1|0.2|0.1|92|IX(e) Unspecified soft tissue sarcomas|74878093|2001
0-14|0.0|0.1|0.0|20|Not classified by ICCC|56086557|2001
0-19|0.0|0.1|0.0|26|Not classified by ICCC|74878093|2001
0-19|0.0|0.1|0.0|26|Not classified by ICCC|74878093|2001
0-14|0.4|0.5|0.4|246|V Retinoblastoma|56086557|2001
0-19|0.3|0.4|0.3|246|V Retinoblastoma|74878093|2001
0-19|0.3|0.4|0.3|246|V Retinoblastoma|74878093|2001
0-14|0.8|0.9|0.9|475|VI Renal tumors|56086557|2001
0-19|0.6|0.7|0.7|500|VI Renal tumors|74878093|2001
0-19|0.6|0.7|0.7|500|VI Renal tumors|74878093|2001
0-14|0.7|0.9|0.8|453|VI(a) Nephroblastoma and other nonepithelial renal tumors|56086557|2001
0-19|0.6|0.7|0.6|456|VI(a) Nephroblastoma and other nonepithelial renal tumors|74878093|2001
0-19|0.6|0.7|0.6|456|VI(a) Nephroblastoma and other nonepithelial renal tumors|74878093|2001
0-14|0.0|0.1|0.0|20|VI(b) Renal carcinomas|56086557|2001
0-19|0.0|0.1|0.1|42|VI(b) Renal carcinomas|74878093|2001
0-19|0.0|0.1|0.1|42|VI(b) Renal carcinomas|74878093|2001
0-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|56086557|2001
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|74878093|2001
0-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|74878093|2001
0-19|0.8|1.0|0.9|672|IV Neuroblastoma and other peripheral nervous cell tumors|74878093|2001
0-14|1.1|1.3|1.2|652|IV(a) Neuroblastoma and ganglioneuroblastoma|56086557|2001
0-19|0.8|0.9|0.9|659|IV(a) Neuroblastoma and ganglioneuroblastoma|74878093|2001
0-19|0.8|0.9|0.9|659|IV(a) Neuroblastoma and ganglioneuroblastoma|74878093|2001
0-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|56086557|2001
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|74878093|2001
0-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|74878093|2001
0-14|0.9|1.1|1.0|577|IX Soft tissue and other extraosseous sarcomas|56086557|2001
0-19|1.1|1.2|1.2|874|IX Soft tissue and other extraosseous sarcomas|74878093|2001
